≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback

Chronic hepatitis NAS

DOID EFO Endpoint Browser PheWeb

CHRONHEP_NAS

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519870

1. Apply sex-specific rule

None

519870

2. Check conditions

None

519870

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

2 out of 7 registries used, show all original rules.

485

4. Check minimum number of events

None

485

5. Include endpoints

None

485

6. Filter based on genotype QC (FinnGen only)

472

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze
DF2

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 3280 1919 1341
Only index persons 2815 1703 1112
Unadjusted period prevalence (%)
Whole population 0.05 0.05 0.04
Only index persons 0.05 0.06 0.04
Median age at first event (years)
Whole population 55.85 57.41 53.52
Only index persons 54.73 56.41 52.15

-FinnGen-

Key figures

All Female Male
Number of individuals 472 307 165
Unadjusted period prevalence (%) 0.10 0.11 0.08
Median age at first event (years) 53.53 53.01 54.52

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
485
Matched controls
4850
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
K73.9
ICD-10 Finland
Chronic hepatitis, unspecified
+∞
307.7
456
*
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
63.2
289.7
167
40
A05AA02
ATC
ursodeoxycholic acid; oral
46.9
194.4
118
33
L04AX01
ATC
azathioprine; systemic
23.3
182.8
146
88
K75.9
ICD-10 Finland
Inflammatory liver disease, unspecified
55.6
150.9
87
19
K73.2
ICD-10 Finland
Chronic active hepatitis, not elsewhere classified
908.3
142.6
133
*
K76.9
ICD-10 Finland
Liver disease, unspecified
44.6
140.0
85
23
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
10.8
134.3
185
262
K74.3
ICD-10 Finland
Primary biliary cirrhosis
62.1
107.0
60
11
A07EA06
ATC
budesonide; oral, local oral
13.5
101.7
105
97
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
7.8
97.4
174
323
K75.4
ICD-10 Finland
Autoimmune hepatitis
494.7
85.9
83
*
K83.0
ICD-10 Finland
Cholangitis
31.2
79.5
53
19
R74.0
ICD-10 Finland
Elevation of levels of transaminase and lactic acid dehydrogenase [LDH]
17.0
73.8
64
43
K74.6
ICD-10 Finland
Other and unspecified cirrhosis of liver
22.4
71.5
54
27
JJ1LE
NOMESCO Finland
Ultrasound elastography of liver
23.5
63.8
47
22
K76.0
ICD-10 Finland
Fatty (change of) liver, not elsewhere classified
12.8
61.6
63
56
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
5.4
59.0
148
365
R17
ICD-10 Finland
Hyperbilirubinaemia, with or without jaundice, not elsewhere classified
19.7
56.6
45
25
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
4.1
51.7
246
976
L01BB02
ATC
mercaptopurine; oral
18.7
46.7
38
22
K73.89
ICD-10 Finland
Other long-term hepatitis, not classified differently
+∞
43.4
41
*
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
11.0
42.2
47
47
JKE98
NOMESCO Finland
Other transduodenal endoscopic operation on bile duct or ampulla of Vater
16.0
37.7
33
22
K73.0
ICD-10 Finland
Chronic persistent hepatitis, not elsewhere classified
205.6
37.3
38
*
L04AA06
ATC
mycophenolic acid; systemic
11.4
35.3
38
36
H02AB06
ATC
prednisolone; systemic
3.1
31.0
307
1748
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.9
30.1
241
1217
ZX120
NOMESCO Finland
Intravenous
4.2
29.3
90
251
K51.5
ICD-10 Finland
Left sided colitis
7.6
29.3
43
61
K51.9
ICD-10 Finland
Ulcerative colitis, unspecified
7.2
29.0
45
68
R18
ICD-10 Finland
Ascites
9.8
28.6
34
37
UJF30
NOMESCO Finland
Ileoscopy through colon
3.7
26.4
96
301
C03DA01
ATC
spironolactone; oral
3.6
26.1
101
330
L04AD01
ATC
ciclosporin; systemic
9.7
25.9
31
34
JL5BG
NOMESCO Finland
MRI examinaiton of bile and pancreas ducts with high intesity magnet
8.8
25.5
33
40
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
8.8
25.5
33
40
I85.9
ICD-10 Finland
Oesophageal varices without bleeding
27.1
24.3
33
13
UJF32
NOMESCO Finland
Coloscopy
2.7
23.8
179
852
208
Kela drug reimbursment
Ulcerative colitis and Crohn's disease
4.8
21.6
51
115
K70.3
ICD-10 Finland
Alcoholic cirrhosis of liver
20.1
21.6
32
17
A07EC02
ATC
mesalazine; oral, rectal
4.4
21.3
57
142
UJK02
NOMESCO Finland
ERCP
7.5
21.0
31
44
TJJ00
NOMESCO Finland
Percutaneous needle biopsy of liver
50.3
20.3
24
5
C03CA01
ATC
furosemide; systemic
2.5
20.1
173
867
A06AD11
ATC
lactulose; oral
3.0
19.5
100
384
N02AX02
ATC
tramadol; systemic, rectal
2.4
19.3
256
1553
Z94.4
ICD-10 Finland
Liver transplant status
31.5
18.5
24
8
TPH04
NOMESCO Finland
Cathetrisation of vein
2.6
18.2
143
683
JN3AD
NOMESCO Finland
Abdominal CT examination
2.9
18.0
97
381
K72.0
ICD-10 Finland
Acute and subacute hepatic failure
186.5
17.6
18
*
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
3.5
17.4
64
200
JJC00
NOMESCO Finland
Allogenic transplantation of liver
41.6
16.4
20
5
A02BC02
ATC
pantoprazole; systemic
2.5
16.0
369
2738
H02AB07
ATC
prednisone; oral
2.8
15.9
96
399
K73.8
ICD-10 Finland
Other chronic hepatitis, not elsewhere classified
+∞
15.7
15
*
JJ9AE
NOMESCO Finland
Ultrasound examination of liver transplant
88.0
15.7
17
*
J01MA02
ATC
ciprofloxacin; systemic
2.2
15.6
216
1300
L04AD02
ATC
tacrolimus; systemic
15.4
15.5
25
17
D64.9
ICD-10 Finland
Anaemia, unspecified
3.1
15.4
70
249
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.2
15.2
215
1303
JL5AG
NOMESCO Finland
Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet
17.2
14.9
23
14
5714B
ICD-9 Finland
Chronic liver disease and cirrhosis, Chronic hepatitis[HEPATITIS CHRONICA ACTIVA (HBSAG-)]
82.7
14.7
16
*
JJA20
NOMESCO Finland
Open biopsy of liver
82.7
14.7
16
*
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
37.3
14.5
18
5
D97
ICPC
Liver disease NOS
23.1
14.3
20
9
K51.8
ICD-10 Finland
Other ulcerative colitis
6.7
14.2
23
36
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.1
13.9
260
1734
UJK12
NOMESCO Finland
Peroral cholangioscopy
+∞
13.6
13
*
JL5SB
NOMESCO Finland
Endoscopic retrograd cholangiopancreaticography
12.0
13.4
24
21
127
Kela drug reimbursment
Transplant complication
10.5
13.1
25
25
K72.9
ICD-10 Finland
Hepatic failure, unspecified
23.3
13.0
18
8
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.6
12.8
44
131
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
3.3
12.7
51
168
C10AC01
ATC
colestyramine; oral
5.0
12.5
27
56
UJD02
NOMESCO Finland
Gastroscopy
3.8
12.3
39
110
JKE02
NOMESCO Finland
Transduodenal endoscopic incision of common bile duct orifice
16.4
12.2
19
12
R94.5
ICD-10 Finland
Abnormal results of liver function studies
9.3
11.9
24
27
K73.80
ICD-10 Finland
Non-alcoholic fatty liver (NASH, Non Alcoholic Steatohepatitis)
19.5
11.7
17
9
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
9.6
11.6
23
25
R74.8
ICD-10 Finland
Abnormal levels of other serum enzymes
3.9
11.6
35
95
K72.1
ICD-10 Finland
Chronic hepatic failure
122.8
11.5
12
*
Z01.8
ICD-10 Finland
Other specified special examinations
2.1
11.2
134
745
C22.0
ICD-10 Finland
Malignant neoplasm: Liver cell carcinoma
25.7
11.2
15
6
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.4
11.2
83
379
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
4.7
11.1
26
58
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.3
10.9
91
438
I85.0
ICD-10 Finland
Oesophageal varices with bleeding
61.4
10.7
12
*
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
4.7
10.6
25
56
A10AB05
ATC
insulin aspart; parenteral
2.8
10.5
54
205
A10AC01
ATC
insulin (human); parenteral
2.9
10.2
52
196
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.6
10.0
62
259
K80.2
ICD-10 Finland
Calculus of gallbladder without cholecystitis
2.4
9.8
73
333
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.1
9.7
107
575
K70.9
ICD-10 Finland
Alcoholic liver disease, unspecified
30.7
9.4
12
*
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.0
9.3
132
774
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.2
9.2
86
431
JKA21
NOMESCO Finland
Laparoscopic cholecystectomy
2.4
9.1
68
310
8170/3-C22.0
ICD-O-3
Hepatocellular carcinoma, NOS, of liver
37.4
9.1
11
*
N17.9
ICD-10 Finland
Acute renal failure, unspecified
3.7
9.0
28
78
K51.1
ICD-10 Finland
Ulcerative (chronic) ileocolitis
9.7
8.8
17
18
N02AA05
ATC
oxycodone; systemic
2.1
8.8
100
541
A10AE04
ATC
insulin glargine; parenteral
2.5
8.8
59
256
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
2.7
8.8
48
188
R50.9
ICD-10 Finland
Fever, unspecified
2.2
8.8
87
447
J01MA12
ATC
levofloxacin; systemic
2.1
8.6
100
545
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
3.9
8.6
25
66
WW500
NOMESCO Finland
Blood transfusion
3.8
8.6
26
71
R10.1
ICD-10 Finland
Pain localized to upper abdomen
2.0
8.5
110
624
JJ3AT
NOMESCO Finland
Cytology of liver with ultrasound guidance
91.6
8.4
9
*
5719X
ICD-9 Finland
Chronic liver disease and cirrhosis, Unspecified chronic liver disease without mention of alcohol
91.6
8.4
9
*
K29.6
ICD-10 Finland
Other gastritis
8.8
8.4
17
20
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.4
8.3
63
289
H02AB04
ATC
methylprednisolone; systemic
2.1
8.3
82
420
XF400
NOMESCO Finland
ECG with 12 standard connections
2.1
8.2
82
423
K74.0
ICD-10 Finland
Hepatic fibrosis
17.5
8.1
12
7
JCA22
NOMESCO Finland
Endoscopic ligature of oesophageal varices
17.5
8.1
12
7
S97
ICPC
Chronic ulcer skin
2.7
8.1
44
172
R10.0
ICD-10 Finland
Acute abdomen
4.1
8.0
22
56
JA2AT
NOMESCO Finland
Abdominal puncture with ultrasound guidance
13.3
7.9
13
10
K80.0
ICD-10 Finland
Calculus of gallbladder with acute cholecystitis
3.4
7.9
28
85
L04AA01
ATC
[U] ciclosporin
9.6
7.8
15
16
K80.5
ICD-10 Finland
Calculus of bile duct without cholangitis or cholecystitis
4.3
7.8
20
48
M05BA04
ATC
alendronic acid; oral
2.5
7.8
52
225
JJ5AT, ,
NOMESCO Finland
45.7
7.7
9
*
K92.1
ICD-10 Finland
Melaena
3.1
7.7
33
113
XG410
NOMESCO Finland
Flow-volume spirometry
3.6
7.6
25
72
C07AG02
ATC
carvedilol; oral
2.8
7.6
38
142
K74.5
ICD-10 Finland
Biliary cirrhosis, unspecified
25.5
7.6
10
*
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.8
7.5
128
791
XW000
NOMESCO Finland
Bone marrow biopsy
3.7
7.5
24
68
K73.1
ICD-10 Finland
Chronic lobular hepatitis, not elsewhere classified
+∞
7.3
7
*
B99
ICD-10 Finland
Other and unspecified infectious diseases
4.4
7.3
18
42
B18.2
ICD-10 Finland
Chronic viral hepatitis C
7.5
7.2
16
22
A02BC01
ATC
omeprazole; systemic
1.8
7.1
138
885
K70.1
ICD-10 Finland
Alcoholic hepatitis
12.3
7.1
12
10
TPH07
NOMESCO Finland
Cathetrisation of artery
2.2
7.1
60
289
K50.8
ICD-10 Finland
Other Crohn disease
5.6
7.0
19
35
O99.6
ICD-10 Finland
Diseases of the digestive system complicating pregnancy, childbirth and the puerperium
14.0
6.9
11
8
H02AB09
ATC
hydrocortisone; systemic
3.9
6.9
20
53
103
Kela drug reimbursment
Diabetes, insulin-treated
1.8
6.8
131
837
V03AE01
ATC
polystyrene sulfonate; oral
9.5
6.8
13
14
K29.3
ICD-10 Finland
Chronic superficial gastritis
3.4
6.6
23
69
Z3231
NOMESCO Finland
Registered nurse
1.8
6.6
134
868
JKE12
NOMESCO Finland
Endoscopic extraction of calculus from bile duct
10.2
6.6
12
12
Z2221
NOMESCO Finland
Medical doctor
1.7
6.6
138
904
0709X
ICD-9 Finland
Viral hepatitis, Unspecified viral hepatitis without mention of hepatic coma
70.7
6.4
7
*
K83.8
ICD-10 Finland
Other specified diseases of biliary tract
70.7
6.4
7
*
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.2
6.4
55
266
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.8
6.4
123
785
K29
ICPC
Cardiovascular sympt/complt other
3.0
6.4
27
92
ZXD05
NOMESCO Finland
Urgent procedure
1.7
6.4
147
987
P15
ICPC
Chronic alcohol abuse
3.4
6.3
22
66
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.3
6.3
51
240
K70.4
ICD-10 Finland
Alcoholic hepatic failure
18.3
6.3
9
5
198
Kela drug reimbursment
Sorafenib
+∞
6.3
6
*
5714X
ICD-9 Finland
Chronic liver disease and cirrhosis, Chronic hepatitis[HEPATITIS CHRONICA ALIA SEU NUD]
+∞
6.3
6
*
5739X
ICD-9 Finland
Other disorders of liver, Unspecified disorder of liver
+∞
6.3
6
*
253, ,
Kela drug reimbursment
27.1
6.2
8
*
K75.2
ICD-10 Finland
Nonspecific reactive hepatitis
27.1
6.2
8
*
3042, ,
Kela drug reimbursment
27.1
6.2
8
*
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
3.2
6.1
24
78
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
3.3
6.1
23
73
A02BC03
ATC
lansoprazole; oral
1.7
6.1
144
972
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.4
6.0
41
179

TimeCodeWAS

↥

TODO / Current known limitations:

  • Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
  • Legend / how to read the glyphs.
  • Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
  • Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
  • Download CSV.
  • No filters and sorters.
  • Limited amount of endpoints (~400) having TimeCodeWAS data.
  • Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
Gastroenterology
10 [38004455]
1.7e+00
3.0e+00
3.9e+00
1.0e+50
5.6e+00
4.0e+00
2.9e+00
cases:16.53%
controls:3.50%
cases:22.93%
controls:1.45%
cases:11.57%
controls:0.27%
cases:40.08%
controls:0.00%
cases:25.16%
controls:0.12%
cases:47.23%
controls:1.64%
cases:46.58%
controls:4.79%
80
169
404
4666
111
70
373
4765
56
13
428
4822
194
0
290
4835
121
6
360
4829
222
79
248
4733
204
218
234
4333
azathioprine; oral, parenteral
L04AX01 [21603927]
3.2e+00
3.3e+00
—
—
3.6e+00
4.4e+00
4.2e+00
cases:8.68%
controls:0.37%
cases:9.09%
controls:0.35%
—
—
—
—
cases:6.65%
controls:0.19%
cases:19.79%
controls:0.31%
cases:20.32%
controls:0.40%
42
18
442
4817
44
17
440
4818
—
—
32
9
449
4826
93
15
377
4797
89
18
349
4533
ursodeoxycholic acid; oral
A05AA02 [21600513]
3.9e+00
4.3e+00
1.0e+50
—
—
5.1e+00
4.7e+00
cases:4.96%
controls:0.10%
cases:7.23%
controls:0.10%
cases:3.72%
controls:0.00%
—
—
—
—
cases:14.47%
controls:0.10%
cases:18.49%
controls:0.20%
24
5
460
4830
35
5
449
4830
18
0
466
4835
—
—
68
5
402
4807
81
9
357
4542
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1920-8 [3013721]
8.8e-01
2.2e+00
3.8e+00
1.0e+50
4.3e+00
2.3e+00
1.7e+00
cases:7.44%
controls:3.23%
cases:11.36%
controls:1.41%
cases:9.92%
controls:0.25%
cases:3.31%
controls:0.00%
cases:6.86%
controls:0.10%
cases:14.04%
controls:1.64%
cases:25.34%
controls:6.09%
36
156
448
4679
55
68
429
4767
48
12
436
4823
16
0
468
4835
33
5
448
4830
66
79
404
4733
111
277
327
4274
Outpatient Visit
OP [9202]
6.0e-01
1.2e+00
1.4e+00
5.9e+00
2.1e+00
2.3e+00
1.5e+00
cases:75.21%
controls:62.38%
cases:70.04%
controls:42.03%
cases:29.13%
controls:9.37%
cases:56.82%
controls:0.37%
cases:45.11%
controls:9.16%
cases:87.45%
controls:42.25%
cases:92.69%
controls:73.15%
364
3016
120
1819
339
2032
145
2803
141
453
343
4382
275
18
209
4817
217
443
264
4392
411
2033
59
2779
406
3329
32
1222
Albumin [Mass/volume] in Serum or Plasma
1751-7 [3024561]
9.1e-01
2.1e+00
3.4e+00
—
3.8e+00
2.3e+00
1.5e+00
cases:8.06%
controls:3.39%
cases:14.05%
controls:1.90%
cases:10.33%
controls:0.37%
—
—
cases:8.32%
controls:0.21%
cases:17.66%
controls:2.06%
cases:27.17%
controls:7.87%
39
164
445
4671
68
92
416
4743
50
18
434
4817
—
40
10
441
4825
83
99
387
4713
119
358
319
4193
Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 [3006140]
1.0e+00
2.1e+00
3.5e+00
1.0e+50
3.4e+00
2.3e+00
1.6e+00
cases:10.74%
controls:4.14%
cases:16.94%
controls:2.44%
cases:16.12%
controls:0.58%
cases:5.79%
controls:0.00%
cases:11.85%
controls:0.46%
cases:21.91%
controls:2.83%
cases:32.88%
controls:9.14%
52
200
432
4635
82
118
402
4717
78
28
406
4807
28
0
456
4835
57
22
424
4813
103
136
367
4676
144
416
294
4135
IgG [Mass/volume] in Serum or Plasma
2465-3 [3005719]
2.3e+00
4.1e+00
—
1.0e+50
—
4.2e+00
2.9e+00
cases:3.93%
controls:0.39%
cases:9.71%
controls:0.19%
—
—
cases:1.65%
controls:0.00%
—
—
cases:12.98%
controls:0.23%
cases:14.84%
controls:0.92%
19
19
465
4816
47
9
437
4826
—
8
0
476
4835
—
61
11
409
4801
65
42
373
4509
mesalazine; oral, rectal
A07EC02 [21600664]
1.8e+00
2.1e+00
2.8e+00
—
2.4e+00
2.0e+00
2.1e+00
cases:4.96%
controls:0.83%
cases:4.75%
controls:0.58%
cases:2.07%
controls:0.12%
—
—
cases:2.08%
controls:0.19%
cases:5.32%
controls:0.75%
cases:7.31%
controls:0.97%
24
40
460
4795
23
28
461
4807
10
6
474
4829
—
10
9
471
4826
25
36
445
4776
32
44
406
4507
Smooth muscle Ab [Titer] in Serum
8095-2 [3007566]
2.8e+00
4.3e+00
—
1.0e+50
1.0e+50
3.5e+00
2.6e+00
cases:2.89%
controls:0.19%
cases:7.23%
controls:0.10%
—
—
cases:1.65%
controls:0.00%
cases:1.87%
controls:0.00%
cases:4.04%
controls:0.12%
cases:5.25%
controls:0.42%
14
9
470
4826
35
5
449
4830
—
8
0
476
4835
9
0
472
4835
19
6
451
4806
23
19
415
4532
prednisolone
A07EA01 [21600653]
1.0e+00
1.7e+00
2.7e+00
—
3.7e+00
2.2e+00
1.2e+00
cases:19.42%
controls:7.94%
cases:15.50%
controls:3.39%
cases:7.02%
controls:0.52%
—
—
cases:13.31%
controls:0.39%
cases:24.26%
controls:3.55%
cases:27.85%
controls:10.46%
94
384
390
4451
75
164
409
4671
34
25
450
4810
—
64
19
417
4816
114
171
356
4641
122
476
316
4075
prednisolone; oral, parenteral
H02AB06 [21602734]
1.0e+00
1.7e+00
2.7e+00
—
3.7e+00
2.2e+00
1.2e+00
cases:19.42%
controls:7.94%
cases:15.50%
controls:3.39%
cases:7.02%
controls:0.52%
—
—
cases:13.31%
controls:0.39%
cases:24.26%
controls:3.55%
cases:27.63%
controls:10.44%
94
384
390
4451
75
164
409
4671
34
25
450
4810
—
64
19
417
4816
114
171
356
4641
121
475
317
4076
Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2324-2 [3026910]
7.9e-01
1.7e+00
3.7e+00
—
3.4e+00
1.7e+00
9.8e-01
cases:13.43%
controls:6.56%
cases:15.29%
controls:3.12%
cases:9.92%
controls:0.27%
—
—
cases:7.69%
controls:0.27%
cases:16.60%
controls:3.66%
cases:30.37%
controls:14.02%
65
317
419
4518
74
151
410
4684
48
13
436
4822
—
37
13
444
4822
78
176
392
4636
133
638
305
3913
Ultrasound examination of upper part of abdomen
JN1AE [2001305517]
2.3e+00
3.7e+00
1.0e+50
1.0e+50
1.0e+50
3.2e+00
3.0e+00
cases:4.13%
controls:0.43%
cases:4.13%
controls:0.10%
cases:2.07%
controls:0.00%
cases:3.31%
controls:0.00%
cases:1.66%
controls:0.00%
cases:5.53%
controls:0.23%
cases:11.64%
controls:0.64%
20
21
464
4814
20
5
464
4830
10
0
474
4835
16
0
468
4835
8
0
473
4835
26
11
444
4801
51
29
387
4522
Internal Medicine
11 [38004456]
1.1e+00
1.7e+00
2.6e+00
—
2.9e+00
2.1e+00
1.4e+00
cases:43.18%
controls:19.94%
cases:33.68%
controls:8.17%
cases:15.91%
controls:1.34%
—
—
cases:21.21%
controls:1.45%
cases:43.83%
controls:8.40%
cases:50.23%
controls:20.59%
209
964
275
3871
163
395
321
4440
77
65
407
4770
—
102
70
379
4765
206
404
264
4408
220
937
218
3614
budesonide; oral, sublingual
A07EA06 [21600658]
2.2e+00
2.8e+00
—
—
—
3.7e+00
3.2e+00
cases:2.48%
controls:0.27%
cases:3.31%
controls:0.21%
—
—
—
—
—
—
cases:7.45%
controls:0.21%
cases:9.36%
controls:0.44%
12
13
472
4822
16
10
468
4825
—
—
—
35
10
435
4802
41
20
397
4531
spironolactone; oral
C03DA01 [21601534]
1.4e+00
1.8e+00
2.3e+00
—
2.9e+00
2.0e+00
1.4e+00
cases:4.13%
controls:1.05%
cases:4.13%
controls:0.70%
cases:1.86%
controls:0.19%
—
—
cases:3.53%
controls:0.21%
cases:5.96%
controls:0.81%
cases:6.85%
controls:1.78%
20
51
464
4784
20
34
464
4801
9
9
475
4826
—
17
10
464
4825
28
39
442
4773
30
81
408
4470
IgM [Mass/volume] in Serum or Plasma
2472-9 [3028026]
2.3e+00
3.8e+00
—
1.0e+50
—
3.4e+00
2.3e+00
cases:3.10%
controls:0.31%
cases:6.82%
controls:0.17%
—
—
cases:1.24%
controls:0.00%
—
—
cases:4.68%
controls:0.17%
cases:7.76%
controls:0.81%
15
15
469
4820
33
8
451
4827
—
6
0
478
4835
—
22
8
448
4804
34
37
404
4514
Prealbumin [Mass/volume] in Serum or Plasma
14338-8 [3013742]
1.8e+00
3.5e+00
—
1.0e+50
—
3.4e+00
2.8e+00
cases:2.27%
controls:0.37%
cases:7.23%
controls:0.23%
—
—
cases:1.45%
controls:0.00%
—
—
cases:8.51%
controls:0.31%
cases:14.38%
controls:1.01%
11
18
473
4817
35
11
449
4824
—
7
0
477
4835
—
40
15
430
4797
63
46
375
4505
INR in Blood by Coagulation assay
34714-6 [3032080]
7.0e-01
1.9e+00
2.7e+00
—
2.6e+00
1.7e+00
1.2e+00
cases:7.02%
controls:3.62%
cases:12.40%
controls:2.01%
cases:10.33%
controls:0.74%
—
—
cases:9.77%
controls:0.77%
cases:14.89%
controls:3.18%
cases:25.34%
controls:9.14%
34
175
450
4660
60
97
424
4738
50
36
434
4799
—
47
37
434
4798
70
153
400
4659
111
416
327
4135
IgA [Mass/volume] in Serum or Plasma
2458-8 [3007164]
1.2e+00
2.6e+00
4.2e+00
1.0e+50
—
2.0e+00
9.4e-01
cases:4.55%
controls:1.47%
cases:7.23%
controls:0.60%
cases:6.20%
controls:0.10%
cases:1.24%
controls:0.00%
—
—
cases:4.47%
controls:0.60%
cases:7.31%
controls:2.99%
22
71
462
4764
35
29
449
4806
30
5
454
4830
6
0
478
4835
—
21
29
449
4783
32
136
406
4415
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 [3035995]
6.4e-01
1.6e+00
2.8e+00
—
3.0e+00
1.7e+00
1.2e+00
cases:15.08%
controls:8.54%
cases:20.04%
controls:5.03%
cases:17.98%
controls:1.30%
—
—
cases:14.14%
controls:0.81%
cases:25.96%
controls:6.30%
cases:39.50%
controls:16.94%
73
413
411
4422
97
243
387
4592
87
63
397
4772
—
68
39
413
4796
122
303
348
4509
173
771
265
3780
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1742-6 [3006923]
2.5e-01
7.6e-01
2.3e+00
4.2e+00
2.2e+00
8.6e-01
3.7e-01
cases:18.60%
controls:15.06%
cases:21.49%
controls:11.40%
cases:19.01%
controls:2.25%
cases:6.61%
controls:0.10%
cases:15.38%
controls:1.96%
cases:26.81%
controls:13.45%
cases:41.78%
controls:33.22%
90
728
394
4107
104
551
380
4284
92
109
392
4726
32
5
452
4830
74
95
407
4740
126
647
344
4165
183
1512
255
3039
Left sided colitis
K51.5 [45533604]
2.6e+00
2.6e+00
—
—
1.0e+50
2.7e+00
2.8e+00
cases:3.10%
controls:0.25%
cases:2.48%
controls:0.19%
—
—
—
—
cases:1.25%
controls:0.00%
cases:2.77%
controls:0.19%
cases:5.48%
controls:0.35%
15
12
469
4823
12
9
472
4826
—
—
6
0
475
4835
13
9
457
4803
24
16
414
4535
Thorax X-ray examination
GD1AA [2001303617]
6.3e-01
1.7e+00
3.0e+00
1.0e+50
2.8e+00
1.3e+00
1.2e+00
cases:7.85%
controls:4.34%
cases:7.44%
controls:1.43%
cases:2.89%
controls:0.14%
cases:2.89%
controls:0.00%
cases:1.66%
controls:0.10%
cases:5.96%
controls:1.72%
cases:18.95%
controls:6.53%
38
210
446
4625
36
69
448
4766
14
7
470
4828
14
0
470
4835
8
5
473
4830
28
83
442
4729
83
297
355
4254
ciclosporin; oral, parenteral
L04AD01 [21603924]
1.9e+00
2.3e+00
—
—
—
3.3e+00
2.9e+00
cases:1.65%
controls:0.25%
cases:1.45%
controls:0.14%
—
—
—
—
—
—
cases:3.40%
controls:0.12%
cases:3.88%
controls:0.22%
8
12
476
4823
7
7
477
4828
—
—
—
16
6
454
4806
17
10
421
4541
methylprednisolone; oral, parenteral
H02AB04 [21602732]
8.5e-01
1.5e+00
2.2e+00
—
2.3e+00
2.0e+00
1.6e+00
cases:5.37%
controls:2.38%
cases:3.31%
controls:0.72%
cases:1.24%
controls:0.14%
—
—
cases:1.46%
controls:0.14%
cases:4.68%
controls:0.69%
cases:6.16%
controls:1.27%
26
115
458
4720
16
35
468
4800
6
7
478
4828
—
7
7
474
4828
22
33
448
4779
27
58
411
4493
Pharmacy visit
OMOP4822462 [581458]
1.2e+00
1.4e+00
8.5e-01
1.8e+00
1.1e+00
1.8e+00
2.1e+00
cases:97.73%
controls:92.74%
cases:94.21%
controls:80.70%
cases:60.74%
controls:39.77%
cases:9.50%
controls:1.70%
cases:68.61%
controls:40.97%
cases:96.38%
controls:81.92%
cases:99.32%
controls:94.73%
473
4484
11
351
456
3902
28
933
294
1923
190
2912
46
82
438
4753
330
1981
151
2854
453
3942
17
870
435
4311
3
240
Other and unspecified abdominal pain
R10.4 [45568113]
7.0e-01
1.5e+00
2.8e+00
—
2.5e+00
1.6e+00
9.6e-01
cases:8.88%
controls:4.63%
cases:6.40%
controls:1.47%
cases:2.07%
controls:0.12%
—
—
cases:1.25%
controls:0.10%
cases:5.74%
controls:1.23%
cases:12.10%
controls:5.01%
43
224
441
4611
31
71
453
4764
10
6
474
4829
—
6
5
475
4830
27
59
443
4753
53
228
385
4323
Differential panel, method unspecified - Blood
69738-3 [42870588]
6.8e-01
1.3e+00
2.8e+00
—
2.5e+00
1.9e+00
1.4e+00
cases:4.96%
controls:2.56%
cases:5.79%
controls:1.57%
cases:5.17%
controls:0.33%
—
—
cases:3.74%
controls:0.31%
cases:10.64%
controls:1.68%
cases:18.04%
controls:5.32%
24
124
460
4711
28
76
456
4759
25
16
459
4819
—
18
15
463
4820
50
81
420
4731
79
242
359
4309
Prothrombin time (PT) actual/Normal
5894-1 [3033658]
7.6e-01
2.2e+00
3.5e+00
1.0e+50
—
2.6e+00
1.7e+00
cases:3.93%
controls:1.88%
cases:7.44%
controls:0.89%
cases:6.82%
controls:0.23%
cases:2.07%
controls:0.00%
—
—
cases:11.28%
controls:0.96%
cases:15.75%
controls:3.38%
19
91
465
4744
36
43
448
4792
33
11
451
4824
10
0
474
4835
—
53
46
417
4766
69
154
369
4397
lactulose; oral
A06AD11 [21600571]
8.5e-01
1.5e+00
2.3e+00
—
2.9e+00
1.8e+00
1.2e+00
cases:3.10%
controls:1.34%
cases:3.31%
controls:0.77%
cases:1.45%
controls:0.14%
—
—
cases:2.49%
controls:0.14%
cases:4.04%
controls:0.67%
cases:5.48%
controls:1.74%
15
65
469
4770
16
37
468
4798
7
7
477
4828
—
12
7
469
4828
19
32
451
4780
24
79
414
4472
Monocytes/Leukocytes in Blood
26485-3 [3019069]
5.0e-01
1.3e+00
2.7e+00
1.0e+50
2.5e+00
1.9e+00
1.3e+00
cases:6.61%
controls:4.12%
cases:8.68%
controls:2.61%
cases:8.06%
controls:0.56%
cases:1.03%
controls:0.00%
cases:5.41%
controls:0.48%
cases:14.89%
controls:2.64%
cases:24.20%
controls:8.31%
32
199
452
4636
42
126
442
4709
39
27
445
4808
5
0
479
4835
26
23
455
4812
70
127
400
4685
106
378
332
4173
Eosinophils/Leukocytes in Blood
26450-7 [3006504]
5.3e-01
1.3e+00
2.7e+00
1.0e+50
2.5e+00
1.8e+00
1.3e+00
cases:6.82%
controls:4.14%
cases:8.68%
controls:2.54%
cases:8.06%
controls:0.58%
cases:1.03%
controls:0.00%
cases:5.41%
controls:0.48%
cases:14.89%
controls:2.68%
cases:24.20%
controls:8.37%
33
200
451
4635
42
123
442
4712
39
28
445
4807
5
0
479
4835
26
23
455
4812
70
129
400
4683
106
381
332
4170
Basophils/Leukocytes in Blood
30180-4 [3022096]
5.3e-01
1.3e+00
2.7e+00
1.0e+50
2.4e+00
1.8e+00
1.3e+00
cases:6.82%
controls:4.12%
cases:8.68%
controls:2.54%
cases:8.06%
controls:0.58%
cases:1.03%
controls:0.00%
cases:5.41%
controls:0.50%
cases:14.89%
controls:2.68%
cases:24.20%
controls:8.31%
33
199
451
4636
42
123
442
4712
39
28
445
4807
5
0
479
4835
26
24
455
4811
70
129
400
4683
106
378
332
4173
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]
1.8e-01
6.0e-01
2.0e+00
3.9e+00
2.2e+00
8.1e-01
2.8e-01
cases:12.60%
controls:10.71%
cases:14.26%
controls:8.40%
cases:13.22%
controls:2.07%
cases:5.58%
controls:0.12%
cases:12.06%
controls:1.53%
cases:20.00%
controls:10.04%
cases:28.77%
controls:23.42%
61
518
423
4317
69
406
415
4429
64
100
420
4735
27
6
457
4829
58
74
423
4761
94
483
376
4329
126
1066
312
3485
Neutrophils/Leukocytes in Blood
26511-6 [3018010]
5.8e-01
1.2e+00
2.7e+00
1.0e+50
2.4e+00
1.8e+00
1.3e+00
cases:7.44%
controls:4.30%
cases:8.88%
controls:2.75%
cases:7.85%
controls:0.58%
cases:1.03%
controls:0.00%
cases:5.20%
controls:0.50%
cases:14.68%
controls:2.68%
cases:23.97%
controls:8.17%
36
208
448
4627
43
133
441
4702
38
28
446
4807
5
0
479
4835
25
24
456
4811
69
129
401
4683
105
372
333
4179
Amylase [Enzymatic activity/volume] in Serum or Plasma
1798-8 [3016771]
8.6e-01
2.1e+00
—
1.0e+50
3.6e+00
1.8e+00
1.1e+00
cases:6.20%
controls:2.71%
cases:6.82%
controls:0.89%
—
—
cases:3.10%
controls:0.00%
cases:3.53%
controls:0.10%
cases:6.81%
controls:1.25%
cases:15.98%
controls:5.89%
30
131
454
4704
33
43
451
4792
—
15
0
469
4835
17
5
464
4830
32
60
438
4752
70
268
368
4283
Lymphocytes/Leukocytes in Blood
26478-8 [3002030]
5.0e-01
1.3e+00
2.6e+00
1.0e+50
2.4e+00
1.8e+00
1.3e+00
cases:6.82%
controls:4.24%
cases:9.09%
controls:2.73%
cases:7.64%
controls:0.60%
cases:1.03%
controls:0.00%
cases:5.61%
controls:0.54%
cases:15.11%
controls:2.74%
cases:24.66%
controls:8.53%
33
205
451
4630
44
132
440
4703
37
29
447
4806
5
0
479
4835
27
26
454
4809
71
132
399
4680
108
388
330
4163
Monocytes [#/volume] in Blood
26484-6 [3001604]
4.3e-01
1.3e+00
2.7e+00
—
2.4e+00
1.8e+00
1.1e+00
cases:6.61%
controls:4.38%
cases:9.50%
controls:2.73%
cases:8.06%
controls:0.60%
—
—
cases:5.61%
controls:0.56%
cases:15.74%
controls:2.93%
cases:23.52%
controls:9.05%
32
212
452
4623
46
132
438
4703
39
29
445
4806
—
27
27
454
4808
74
141
396
4671
103
412
335
4139
Basophils [#/volume] in Blood
26444-0 [3006315]
4.3e-01
1.3e+00
2.6e+00
—
2.4e+00
1.8e+00
1.1e+00
cases:6.61%
controls:4.38%
cases:9.50%
controls:2.75%
cases:8.06%
controls:0.62%
—
—
cases:5.61%
controls:0.56%
cases:15.74%
controls:2.97%
cases:23.97%
controls:9.14%
32
212
452
4623
46
133
438
4702
39
30
445
4805
—
27
27
454
4808
74
143
396
4669
105
416
333
4135
Eosinophils [#/volume] in Blood
26449-9 [3013115]
4.4e-01
1.3e+00
2.7e+00
—
2.4e+00
1.8e+00
1.1e+00
cases:7.23%
controls:4.78%
cases:9.50%
controls:2.81%
cases:8.47%
controls:0.62%
—
—
cases:5.61%
controls:0.56%
cases:15.96%
controls:3.08%
cases:24.43%
controls:9.51%
35
231
449
4604
46
136
438
4699
41
30
443
4805
—
27
27
454
4808
75
148
395
4664
107
433
331
4118
Lymphocytes [#/volume] in Blood
26474-7 [3019198]
4.8e-01
1.3e+00
2.6e+00
—
2.4e+00
1.8e+00
1.1e+00
cases:7.44%
controls:4.76%
cases:9.92%
controls:2.90%
cases:8.06%
controls:0.66%
—
—
cases:5.82%
controls:0.58%
cases:16.38%
controls:3.05%
cases:24.66%
controls:9.47%
36
230
448
4605
48
140
436
4695
39
32
445
4803
—
28
28
453
4807
77
147
393
4665
108
431
330
4120
Upper gastrointestinal surgery
106 [44777669]
7.5e-01
1.3e+00
2.3e+00
1.0e+50
2.3e+00
1.4e+00
1.1e+00
cases:12.40%
controls:6.29%
cases:7.64%
controls:2.30%
cases:3.51%
controls:0.35%
cases:1.86%
controls:0.00%
cases:2.70%
controls:0.27%
cases:9.15%
controls:2.35%
cases:20.32%
controls:8.13%
60
304
424
4531
37
111
447
4724
17
17
467
4818
9
0
475
4835
13
13
468
4822
43
113
427
4699
89
370
349
4181
Platelets [#/volume] in Blood
26515-7 [3007461]
1.8e-01
5.4e-01
1.9e+00
4.0e+00
2.0e+00
5.6e-01
1.7e-01
cases:20.66%
controls:17.85%
cases:23.14%
controls:14.87%
cases:18.80%
controls:3.35%
cases:7.23%
controls:0.14%
cases:17.46%
controls:2.85%
cases:27.23%
controls:17.64%
cases:42.69%
controls:38.63%
100
863
384
3972
112
719
372
4116
91
162
393
4673
35
7
449
4828
84
138
397
4697
128
849
342
3963
187
1758
251
2793
Hemoglobin [Mass/volume] in Blood
718-7 [3000963]
1.8e-01
5.3e-01
1.9e+00
4.0e+00
2.0e+00
5.5e-01
1.6e-01
cases:20.66%
controls:17.89%
cases:23.14%
controls:14.99%
cases:18.80%
controls:3.35%
cases:7.23%
controls:0.14%
cases:17.67%
controls:2.85%
cases:27.23%
controls:17.73%
cases:42.69%
controls:38.87%
100
865
384
3970
112
725
372
4110
91
162
393
4673
35
7
449
4828
85
138
396
4697
128
853
342
3959
187
1769
251
2782
MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]
1.8e-01
5.4e-01
1.9e+00
4.0e+00
2.0e+00
5.6e-01
1.7e-01
cases:20.66%
controls:17.85%
cases:23.14%
controls:14.93%
cases:18.80%
controls:3.35%
cases:7.23%
controls:0.14%
cases:17.46%
controls:2.85%
cases:27.23%
controls:17.66%
cases:42.69%
controls:38.67%
100
863
384
3972
112
722
372
4113
91
162
393
4673
35
7
449
4828
84
138
397
4697
128
850
342
3962
187
1760
251
2791
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]
1.8e-01
5.4e-01
1.9e+00
4.0e+00
2.0e+00
5.6e-01
1.6e-01
cases:20.66%
controls:17.87%
cases:23.14%
controls:14.95%
cases:18.80%
controls:3.37%
cases:7.23%
controls:0.14%
cases:17.46%
controls:2.85%
cases:27.23%
controls:17.68%
cases:42.69%
controls:38.74%
100
864
384
3971
112
723
372
4112
91
163
393
4672
35
7
449
4828
84
138
397
4697
128
851
342
3961
187
1763
251
2788
MCH [Entitic mass]
28539-5 [3035941]
1.7e-01
5.4e-01
1.9e+00
4.0e+00
2.0e+00
5.5e-01
1.6e-01
cases:20.45%
controls:17.83%
cases:23.14%
controls:14.95%
cases:18.80%
controls:3.35%
cases:7.23%
controls:0.14%
cases:17.46%
controls:2.85%
cases:27.02%
controls:17.64%
cases:42.47%
controls:38.65%
99
862
385
3973
112
723
372
4112
91
162
393
4673
35
7
449
4828
84
138
397
4697
127
849
343
3963
186
1759
252
2792
Erythrocytes [#/volume] in Blood
26453-1 [3026361]
1.7e-01
5.4e-01
1.9e+00
4.0e+00
2.0e+00
5.5e-01
1.6e-01
cases:20.45%
controls:17.85%
cases:23.14%
controls:14.95%
cases:18.80%
controls:3.35%
cases:7.23%
controls:0.14%
cases:17.46%
controls:2.85%
cases:27.02%
controls:17.66%
cases:42.47%
controls:38.72%
99
863
385
3972
112
723
372
4112
91
162
393
4673
35
7
449
4828
84
138
397
4697
127
850
343
3962
186
1762
252
2789
Leukocytes [#/volume] in Blood
26464-8 [3010813]
1.8e-01
5.3e-01
1.9e+00
4.0e+00
2.0e+00
5.5e-01
1.6e-01
cases:20.66%
controls:17.87%
cases:23.14%
controls:15.02%
cases:18.80%
controls:3.35%
cases:7.23%
controls:0.14%
cases:17.46%
controls:2.87%
cases:27.23%
controls:17.71%
cases:42.69%
controls:38.80%
100
864
384
3971
112
726
372
4109
91
162
393
4673
35
7
449
4828
84
139
397
4696
128
852
342
3960
187
1766
251
2785
Ferritin [Mass/volume] in Serum or Plasma
2276-4 [3001122]
7.5e-01
1.5e+00
3.0e+00
—
1.9e+00
1.0e+00
6.4e-01
cases:5.79%
controls:2.81%
cases:7.85%
controls:1.92%
cases:4.96%
controls:0.25%
—
—
cases:1.87%
controls:0.29%
cases:6.38%
controls:2.35%
cases:14.38%
controls:8.15%
28
136
456
4699
38
93
446
4742
24
12
460
4823
—
9
14
472
4821
30
113
440
4699
63
371
375
4180
Outpatient Hospital
22 [8756]
6.5e-01
1.1e+00
2.3e+00
—
2.5e+00
1.2e+00
8.3e-01
cases:37.81%
controls:24.07%
cases:19.63%
controls:7.26%
cases:7.85%
controls:0.83%
—
—
cases:8.94%
controls:0.77%
cases:19.79%
controls:6.69%
cases:37.67%
controls:20.87%
183
1164
301
3671
95
351
389
4484
38
40
446
4795
—
43
37
438
4798
93
322
377
4490
165
950
273
3601
Mitochondria Ab [Titer] in Serum
20483-4 [3034770]
2.7e+00
—
—
1.0e+50
1.0e+50
3.4e+00
2.5e+00
cases:2.89%
controls:0.21%
—
—
—
—
cases:1.45%
controls:0.00%
cases:2.08%
controls:0.00%
cases:3.62%
controls:0.12%
cases:5.02%
controls:0.42%
14
10
470
4825
—
—
7
0
477
4835
10
0
471
4835
17
6
453
4806
22
19
416
4532
Ulcerative colitis, unspecified
K51.9 [45605941]
2.9e+00
2.9e+00
—
—
—
—
2.8e+00
cases:3.51%
controls:0.21%
cases:2.27%
controls:0.12%
—
—
—
—
—
—
—
—
cases:4.11%
controls:0.26%
17
10
467
4825
11
6
473
4829
—
—
—
—
18
12
420
4539
Hepatitis C virus Ab [Presence] in Serum
16128-1 [3017143]
1.5e+00
3.2e+00
—
—
—
2.4e+00
1.3e+00
cases:3.93%
controls:0.87%
cases:6.82%
controls:0.29%
—
—
—
—
—
—
cases:2.55%
controls:0.23%
cases:4.57%
controls:1.34%
19
42
465
4793
33
14
451
4821
—
—
—
12
11
458
4801
20
61
418
4490
Neutrophils [#/volume] in Blood by Automated count
751-8 [3013650]
4.5e-01
1.2e+00
2.3e+00
—
2.2e+00
1.7e+00
1.1e+00
cases:8.06%
controls:5.32%
cases:10.33%
controls:3.45%
cases:8.68%
controls:0.97%
—
—
cases:6.65%
controls:0.77%
cases:16.60%
controls:3.60%
cases:26.26%
controls:10.48%
39
257
445
4578
50
167
434
4668
42
47
442
4788
—
32
37
449
4798
78
173
392
4639
115
477
323
4074
Glucose [Moles/volume] in Serum or Plasma
14749-6 [3013826]
-2.3e-02
1.2e+00
2.6e+00
1.0e+50
2.7e+00
1.2e+00
6.5e-01
cases:4.96%
controls:5.07%
cases:7.02%
controls:2.23%
cases:4.13%
controls:0.31%
cases:2.07%
controls:0.00%
cases:3.95%
controls:0.27%
cases:9.15%
controls:2.89%
cases:19.41%
controls:11.21%
24
245
460
4590
34
108
450
4727
20
15
464
4820
10
0
474
4835
19
13
462
4822
43
139
427
4673
85
510
353
4041
Inpatient Hospital
21 [8717]
6.5e-01
1.3e+00
1.9e+00
—
2.5e+00
1.1e+00
9.5e-01
cases:47.52%
controls:32.16%
cases:29.13%
controls:10.13%
cases:9.30%
controls:1.57%
—
—
cases:12.89%
controls:1.24%
cases:24.68%
controls:9.85%
cases:48.86%
controls:27.05%
230
1555
254
3280
141
490
343
4345
45
76
439
4759
—
62
60
419
4775
116
474
354
4338
214
1231
224
3320
Normoblasts [#/volume] in Blood
715-3 [3021589]
5.7e-01
1.0e+00
2.3e+00
—
2.4e+00
1.5e+00
9.7e-01
cases:5.99%
controls:3.47%
cases:8.06%
controls:3.10%
cases:8.06%
controls:0.85%
—
—
cases:5.82%
controls:0.56%
cases:12.98%
controls:3.30%
cases:17.35%
controls:7.36%
29
168
455
4667
39
150
445
4685
39
41
445
4794
—
28
27
453
4808
61
159
409
4653
76
335
362
4216
CBC panel - Blood by Automated count
58410-2 [40761511]
1.3e-01
4.4e-01
1.8e+00
3.7e+00
2.0e+00
5.9e-01
2.1e-01
cases:16.53%
controls:14.85%
cases:15.50%
controls:10.53%
cases:11.36%
controls:2.01%
cases:4.96%
controls:0.12%
cases:11.43%
controls:1.72%
cases:19.79%
controls:12.07%
cases:35.16%
controls:30.45%
80
718
404
4117
75
509
409
4326
55
97
429
4738
24
6
460
4829
55
83
426
4752
93
581
377
4231
154
1386
284
3165
Bilirubin.conjugated [Moles/volume] in Serum or Plasma
29760-6 [3005772]
9.0e-01
2.9e+00
—
1.0e+50
1.0e+50
3.1e+00
2.1e+00
cases:2.07%
controls:0.85%
cases:5.17%
controls:0.31%
—
—
cases:1.45%
controls:0.00%
cases:3.74%
controls:0.00%
cases:5.96%
controls:0.29%
cases:11.19%
controls:1.49%
10
41
474
4794
25
15
459
4820
—
7
0
477
4835
18
0
463
4835
28
14
442
4798
49
68
389
4483
Sicca syndrome [Sjögren]
M35.0 [45562711]
2.4e+00
2.9e+00
—
—
—
—
2.7e+00
cases:1.65%
controls:0.14%
cases:1.86%
controls:0.10%
—
—
—
—
—
—
—
—
cases:2.74%
controls:0.20%
8
7
476
4828
9
5
475
4830
—
—
—
—
12
9
426
4542
Ileoscopy through colon
UJF30 [2001305028]
1.4e+00
1.9e+00
—
—
—
2.1e+00
2.5e+00
cases:2.48%
controls:0.60%
cases:1.65%
controls:0.25%
—
—
—
—
—
—
cases:1.91%
controls:0.23%
cases:7.08%
controls:0.64%
12
29
472
4806
8
12
476
4823
—
—
—
9
11
461
4801
31
29
407
4522
Emergency Medicine
93 [38004510]
3.0e-01
1.1e+00
2.8e+00
—
2.6e+00
9.2e-01
4.8e-01
cases:7.64%
controls:5.79%
cases:7.85%
controls:2.73%
cases:4.96%
controls:0.31%
—
—
cases:2.49%
controls:0.19%
cases:8.51%
controls:3.57%
cases:20.78%
controls:13.91%
37
280
447
4555
38
132
446
4703
24
15
460
4820
—
12
9
469
4826
40
172
430
4640
91
633
347
3918
pH of Serum or Plasma
2753-2 [3018418]
4.8e-01
1.2e+00
2.1e+00
—
2.2e+00
1.4e+00
8.3e-01
cases:3.31%
controls:2.07%
cases:3.51%
controls:1.03%
cases:1.86%
controls:0.23%
—
—
cases:1.66%
controls:0.19%
cases:5.11%
controls:1.37%
cases:10.50%
controls:4.88%
16
100
468
4735
17
50
467
4785
9
11
475
4824
—
8
9
473
4826
24
66
446
4746
46
222
392
4329
Emergency Room Visit
ER [9203]
5.5e-01
1.3e+00
2.3e+00
—
1.7e+00
1.0e+00
8.9e-01
cases:42.56%
controls:29.93%
cases:28.72%
controls:10.22%
cases:11.36%
controls:1.26%
—
—
cases:7.28%
controls:1.41%
cases:25.32%
controls:10.79%
cases:51.60%
controls:30.41%
206
1447
278
3388
139
494
345
4341
55
61
429
4774
—
35
68
446
4767
119
519
351
4293
226
1384
212
3167
Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method
4537-7 [3013707]
4.0e-01
1.1e+00
2.4e+00
—
2.1e+00
1.2e+00
7.5e-01
cases:11.98%
controls:8.40%
cases:13.02%
controls:4.72%
cases:9.09%
controls:0.87%
—
—
cases:4.57%
controls:0.56%
cases:14.89%
controls:5.05%
cases:29.68%
controls:16.61%
58
406
426
4429
63
228
421
4607
44
42
440
4793
—
22
27
459
4808
70
243
400
4569
130
756
308
3795
General Surgery
2 [38004447]
7.2e-01
1.2e+00
2.1e+00
1.0e+50
1.8e+00
1.0e+00
8.1e-01
cases:32.02%
controls:18.66%
cases:15.70%
controls:5.42%
cases:5.37%
controls:0.70%
cases:3.51%
controls:0.00%
cases:4.78%
controls:0.81%
cases:14.04%
controls:5.65%
cases:29.45%
controls:15.62%
155
902
329
3933
76
262
408
4573
26
34
458
4801
17
0
467
4835
23
39
458
4796
66
272
404
4540
129
711
309
3840
Coloscopy
UJF32 [2001305029]
7.7e-01
1.8e+00
2.3e+00
—
—
1.3e+00
1.4e+00
cases:5.99%
controls:2.87%
cases:4.13%
controls:0.70%
cases:1.24%
controls:0.12%
—
—
—
—
cases:3.40%
controls:1.00%
cases:12.10%
controls:3.43%
29
139
455
4696
20
34
464
4801
6
6
478
4829
—
—
16
48
454
4764
53
156
385
4395
Phosphatidylethanol [Mass/volume] in Blood
74661-0 [44816559]
—
3.2e+00
—
—
—
2.3e+00
1.8e+00
—
—
cases:2.48%
controls:0.10%
—
—
—
—
—
—
cases:1.49%
controls:0.15%
cases:2.97%
controls:0.53%
—
12
5
472
4830
—
—
—
7
7
463
4805
13
24
425
4527
furosemide; oral, parenteral
C03CA01 [21601518]
8.9e-01
1.1e+00
1.5e+00
—
1.4e+00
1.4e+00
1.0e+00
cases:9.50%
controls:4.14%
cases:8.06%
controls:2.94%
cases:3.72%
controls:0.83%
—
—
cases:3.12%
controls:0.81%
cases:11.49%
controls:3.08%
cases:14.38%
controls:5.84%
46
200
438
4635
39
142
445
4693
18
40
466
4795
—
15
39
466
4796
54
148
416
4664
63
266
375
4285
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
3.6e-01
8.8e-01
2.3e+00
—
2.4e+00
1.0e+00
5.9e-01
cases:17.56%
controls:12.97%
cases:19.21%
controls:9.00%
cases:14.67%
controls:1.65%
—
—
cases:13.10%
controls:1.32%
cases:23.83%
controls:10.16%
cases:41.10%
controls:27.80%
85
627
399
4208
93
435
391
4400
71
80
413
4755
—
63
64
418
4771
112
489
358
4323
180
1265
258
3286
pantoprazole; oral, parenteral
A02BC02 [21600097]
6.4e-01
9.5e-01
1.4e+00
—
2.0e+00
1.3e+00
8.8e-01
cases:21.07%
controls:12.35%
cases:16.12%
controls:6.93%
cases:5.79%
controls:1.47%
—
—
cases:8.94%
controls:1.30%
cases:22.98%
controls:7.23%
cases:33.79%
controls:17.47%
102
597
382
4238
78
335
406
4500
28
71
456
4764
—
43
63
438
4772
108
348
362
4464
148
795
290
3756
Nuclear Ab [Titer] in Serum
29953-7 [3037522]
9.9e-01
2.9e+00
—
1.0e+50
1.0e+50
2.8e+00
1.5e+00
cases:3.10%
controls:1.18%
cases:6.82%
controls:0.41%
—
—
cases:1.45%
controls:0.00%
cases:2.08%
controls:0.00%
cases:4.68%
controls:0.31%
cases:8.45%
controls:2.04%
15
57
469
4778
33
20
451
4815
—
7
0
477
4835
10
0
471
4835
22
15
448
4797
37
93
401
4458
General Practice
1 [38004446]
5.1e-01
1.1e+00
1.6e+00
—
2.4e+00
1.0e+00
5.0e-01
cases:14.26%
controls:9.08%
cases:11.36%
controls:4.16%
cases:3.10%
controls:0.66%
—
—
cases:4.57%
controls:0.43%
cases:9.36%
controls:3.64%
cases:18.72%
controls:12.22%
69
439
415
4396
55
201
429
4634
15
32
469
4803
—
22
21
459
4814
44
175
426
4637
82
556
356
3995
Short blood count panel - Blood
55429-5 [40758558]
4.9e-01
9.5e-01
1.8e+00
—
2.1e+00
1.3e+00
9.8e-01
cases:3.72%
controls:2.32%
cases:3.51%
controls:1.39%
cases:2.69%
controls:0.48%
—
—
cases:2.08%
controls:0.27%
cases:5.32%
controls:1.48%
cases:11.64%
controls:4.72%
18
112
466
4723
17
67
467
4768
13
23
471
4812
—
10
13
471
4822
25
71
445
4741
51
215
387
4336
Hepatitis B virus surface Ag [Presence] in Serum
5195-3 [3019284]
1.2e+00
2.9e+00
—
1.0e+50
1.0e+50
2.1e+00
8.6e-01
cases:4.13%
controls:1.22%
cases:6.82%
controls:0.41%
—
—
cases:1.24%
controls:0.00%
cases:2.49%
controls:0.00%
cases:2.77%
controls:0.35%
cases:4.57%
controls:1.98%
20
59
464
4776
33
20
451
4815
—
6
0
478
4835
12
0
469
4835
13
17
457
4795
20
90
418
4461
CBC W Ordered Manual Differential panel - Blood
57782-5 [40760892]
2.4e-01
1.1e+00
2.4e+00
—
2.0e+00
1.8e+00
7.0e-01
cases:2.07%
controls:1.63%
cases:2.48%
controls:0.85%
cases:2.07%
controls:0.19%
—
—
cases:1.25%
controls:0.17%
cases:6.17%
controls:1.08%
cases:7.99%
controls:4.15%
10
79
474
4756
12
41
472
4794
10
9
474
4826
—
6
8
475
4827
29
52
441
4760
35
189
403
4362
Other and unspecified cirrhosis of liver
K74.6 [45538546]
—
—
—
—
—
3.2e+00
3.6e+00
—
—
—
—
—
—
—
—
—
—
cases:2.55%
controls:0.10%
cases:4.79%
controls:0.13%
—
—
—
—
—
12
5
458
4807
21
6
417
4545
Tissue transglutaminase IgA Ab [Units/volume] in Serum
31017-7 [3019050]
8.0e-01
2.0e+00
3.5e+00
—
—
1.4e+00
4.3e-01
cases:4.13%
controls:1.90%
cases:4.75%
controls:0.70%
cases:3.31%
controls:0.10%
—
—
—
—
cases:2.77%
controls:0.73%
cases:5.48%
controls:3.65%
20
92
464
4743
23
34
461
4801
16
5
468
4830
—
—
13
35
457
4777
24
166
414
4385
Ulcerative colitis and Crohn's disease
208 [2001600206]
1.9e+00
2.5e+00
—
—
—
—
2.4e+00
cases:1.65%
controls:0.25%
cases:1.24%
controls:0.10%
—
—
—
—
—
—
—
—
cases:1.14%
controls:0.11%
8
12
476
4823
6
5
478
4830
—
—
—
—
5
5
433
4546
Bacteria identified in Blood by Culture
600-7 [3023368]
5.9e-01
1.6e+00
2.9e+00
1.0e+50
—
1.5e+00
7.7e-01
cases:2.69%
controls:1.51%
cases:2.89%
controls:0.60%
cases:1.86%
controls:0.10%
cases:1.45%
controls:0.00%
—
—
cases:2.98%
controls:0.71%
cases:8.68%
controls:4.20%
13
73
471
4762
14
29
470
4806
9
5
475
4830
7
0
477
4835
—
14
34
456
4778
38
191
400
4360
Infectious Disease
44 [38004484]
1.1e+00
1.9e+00
2.3e+00
1.0e+50
—
2.0e+00
1.7e+00
cases:3.10%
controls:1.03%
cases:2.89%
controls:0.46%
cases:1.03%
controls:0.10%
cases:1.65%
controls:0.00%
—
—
cases:4.04%
controls:0.56%
cases:6.62%
controls:1.27%
15
50
469
4785
14
22
470
4813
5
5
479
4830
8
0
476
4835
—
19
27
451
4785
29
58
409
4493
Emergency Room and Inpatient Visit
ERIP [262]
6.4e-01
1.2e+00
2.5e+00
1.0e+50
2.8e+00
1.4e+00
6.2e-01
cases:2.48%
controls:1.32%
cases:2.27%
controls:0.66%
cases:1.24%
controls:0.10%
cases:3.51%
controls:0.00%
cases:1.66%
controls:0.10%
cases:4.04%
controls:1.02%
cases:7.99%
controls:4.48%
12
64
472
4771
11
32
473
4803
6
5
478
4830
17
0
467
4835
8
5
473
4830
19
49
451
4763
35
204
403
4347
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]
3.7e-01
9.8e-01
1.8e+00
—
2.2e+00
8.5e-01
8.8e-01
cases:5.17%
controls:3.64%
cases:4.75%
controls:1.84%
cases:2.07%
controls:0.35%
—
—
cases:2.29%
controls:0.27%
cases:5.53%
controls:2.45%
cases:16.67%
controls:7.65%
25
176
459
4659
23
89
461
4746
10
17
474
4818
—
11
13
470
4822
26
118
444
4694
73
348
365
4203
prednisone
A07EA03 [21600655]
1.6e+00
2.0e+00
—
—
—
1.8e+00
1.2e+00
cases:6.61%
controls:1.47%
cases:3.93%
controls:0.54%
—
—
—
—
—
—
cases:4.26%
controls:0.73%
cases:5.71%
controls:1.74%
32
71
452
4764
19
26
465
4809
—
—
—
20
35
450
4777
25
79
413
4472
prednisone; oral
H02AB07 [21602735]
1.6e+00
2.0e+00
—
—
—
1.8e+00
1.2e+00
cases:6.61%
controls:1.47%
cases:3.93%
controls:0.54%
—
—
—
—
—
—
cases:4.26%
controls:0.73%
cases:5.71%
controls:1.74%
32
71
452
4764
19
26
465
4809
—
—
—
20
35
450
4777
25
79
413
4472
Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
30248-9 [3015399]
6.5e-01
1.5e+00
—
—
2.7e+00
1.4e+00
1.1e+00
cases:2.89%
controls:1.53%
cases:3.93%
controls:0.89%
—
—
—
—
cases:1.46%
controls:0.10%
cases:4.47%
controls:1.18%
cases:11.19%
controls:4.11%
14
74
470
4761
19
43
465
4792
—
—
7
5
474
4830
21
57
449
4755
49
187
389
4364
Esophagoscopy, gastroscopy and duodenoscopy
UJD10 [2001304788]
1.0e+00
1.9e+00
—
1.0e+50
—
2.1e+00
1.5e+00
cases:8.68%
controls:3.35%
cases:6.40%
controls:1.01%
—
—
cases:1.65%
controls:0.00%
—
—
cases:9.36%
controls:1.21%
cases:14.84%
controls:3.60%
42
162
442
4673
31
49
453
4786
—
8
0
476
4835
—
44
58
426
4754
65
164
373
4387
Anaemia, unspecified
D64.9 [45600610]
1.0e+00
2.7e+00
—
—
—
2.5e+00
1.3e+00
cases:1.24%
controls:0.46%
cases:1.45%
controls:0.10%
—
—
—
—
—
—
cases:2.34%
controls:0.19%
cases:2.74%
controls:0.75%
6
22
478
4813
7
5
477
4830
—
—
—
11
9
459
4803
12
34
426
4517
Connective tissue diseases, rheumatoid arthritis and comparable disease
202 [2001600200]
2.2e+00
2.2e+00
—
—
—
—
2.2e+00
cases:5.17%
controls:0.60%
cases:2.27%
controls:0.27%
—
—
—
—
—
—
—
—
cases:5.25%
controls:0.64%
25
29
459
4806
11
13
473
4822
—
—
—
—
23
29
415
4522
tramadol; oral, parenteral, rectal
N02AX02 [21604298]
8.2e-01
1.1e+00
1.2e+00
—
2.1e+00
1.4e+00
1.1e+00
cases:13.64%
controls:6.49%
cases:6.82%
controls:2.48%
cases:2.07%
controls:0.64%
—
—
cases:4.37%
controls:0.56%
cases:9.36%
controls:2.45%
cases:19.41%
controls:7.32%
66
314
418
4521
33
120
451
4715
10
31
474
4804
—
21
27
460
4808
44
118
426
4694
85
333
353
4218
Iron/Transferrin [Ratio] in Serum or Plasma
60517-0 [40763571]
1.1e+00
2.4e+00
—
—
—
2.5e+00
1.6e+00
cases:2.07%
controls:0.72%
cases:4.75%
controls:0.46%
—
—
—
—
—
—
cases:4.26%
controls:0.35%
cases:8.22%
controls:1.82%
10
35
474
4800
23
22
461
4813
—
—
—
20
17
450
4795
36
83
402
4468
Intravenous
ZX120 [2001311495]
6.4e-01
1.7e+00
—
—
—
2.8e+00
1.9e+00
cases:1.45%
controls:0.77%
cases:1.86%
controls:0.33%
—
—
—
—
—
—
cases:3.40%
controls:0.21%
cases:5.02%
controls:0.77%
7
37
477
4798
9
16
475
4819
—
—
—
16
10
454
4802
22
35
416
4516
Laboratory Visit
OMOP4822461 [32036]
6.8e-02
2.9e-01
1.5e+00
3.5e+00
1.5e+00
3.3e-01
9.5e-02
cases:21.69%
controls:20.56%
cases:24.79%
controls:19.75%
cases:21.69%
controls:5.77%
cases:9.50%
controls:0.33%
cases:19.75%
controls:5.23%
cases:29.57%
controls:23.23%
cases:45.43%
controls:43.09%
105
994
379
3841
120
955
364
3880
105
279
379
4556
46
16
438
4819
95
253
386
4582
139
1118
331
3694
199
1961
239
2590
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]
2.9e-01
1.0e+00
1.8e+00
—
1.9e+00
8.4e-01
8.6e-01
cases:5.37%
controls:4.07%
cases:5.99%
controls:2.21%
cases:2.48%
controls:0.43%
—
—
cases:2.29%
controls:0.35%
cases:6.60%
controls:2.95%
cases:19.18%
controls:9.12%
26
197
458
4638
29
107
455
4728
12
21
472
4814
—
11
17
470
4818
31
142
439
4670
84
415
354
4136
Transferrin [Mass/volume] in Serum or Plasma
3034-6 [3004789]
9.3e-01
2.4e+00
—
—
—
2.5e+00
1.4e+00
cases:2.07%
controls:0.83%
cases:5.17%
controls:0.48%
—
—
—
—
—
—
cases:4.47%
controls:0.37%
cases:7.99%
controls:2.04%
10
40
474
4795
25
23
459
4812
—
—
—
21
18
449
4794
35
93
403
4458
Pulmonary Disease
29 [38004472]
5.9e-01
8.8e-01
1.5e+00
—
1.4e+00
1.3e+00
6.7e-01
cases:9.92%
controls:5.77%
cases:6.61%
controls:2.85%
cases:1.86%
controls:0.41%
—
—
cases:2.29%
controls:0.56%
cases:8.30%
controls:2.41%
cases:12.79%
controls:7.01%
48
279
436
4556
32
138
452
4697
9
20
475
4815
—
11
27
470
4808
39
116
431
4696
56
319
382
4232
Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
21573-1 [3003031]
1.3e+00
2.3e+00
—
—
—
1.4e+00
1.3e+00
cases:3.51%
controls:0.99%
cases:4.34%
controls:0.46%
—
—
—
—
—
—
cases:2.34%
controls:0.56%
cases:5.94%
controls:1.67%
17
48
467
4787
21
22
463
4813
—
—
—
11
27
459
4785
26
76
412
4475
Iron [Moles/volume] in Serum or Plasma
14798-3 [3022948]
7.7e-01
2.5e+00
—
—
—
2.4e+00
1.4e+00
cases:2.07%
controls:0.97%
cases:5.58%
controls:0.50%
—
—
—
—
—
—
cases:4.26%
controls:0.39%
cases:8.45%
controls:2.31%
10
47
474
4788
27
24
457
4811
—
—
—
20
19
450
4793
37
105
401
4446
aPTT in Platelet poor plasma by Coagulation assay
14979-9 [3018677]
1.1e+00
2.1e+00
—
—
—
1.8e+00
1.2e+00
cases:2.69%
controls:0.93%
cases:3.10%
controls:0.39%
—
—
—
—
—
—
cases:2.77%
controls:0.48%
cases:7.08%
controls:2.31%
13
45
471
4790
15
19
469
4816
—
—
—
13
23
457
4789
31
105
407
4446
Calprotectin [Mass/mass] in Stool
38445-3 [3048689]
1.4e+00
1.7e+00
—
—
—
1.9e+00
9.9e-01
cases:2.69%
controls:0.66%
cases:2.48%
controls:0.46%
—
—
—
—
—
—
cases:2.98%
controls:0.46%
cases:6.16%
controls:2.37%
13
32
471
4803
12
22
472
4813
—
—
—
14
22
456
4790
27
108
411
4443
Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
1805-1 [3016417]
5.8e-01
1.9e+00
—
—
—
2.3e+00
1.8e+00
cases:1.03%
controls:0.58%
cases:1.65%
controls:0.25%
—
—
—
—
—
—
cases:1.49%
controls:0.15%
cases:5.71%
controls:1.03%
5
28
479
4807
8
12
476
4823
—
—
—
7
7
463
4805
25
47
413
4504
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 [40764999]
3.6e-01
6.4e-01
2.1e+00
—
2.0e+00
6.6e-01
6.2e-01
cases:13.43%
controls:9.78%
cases:14.46%
controls:8.17%
cases:11.98%
controls:1.61%
—
—
cases:8.94%
controls:1.37%
cases:17.02%
controls:9.56%
cases:35.39%
controls:22.81%
65
473
419
4362
70
395
414
4440
58
78
426
4757
—
43
66
438
4769
80
460
390
4352
155
1038
283
3513
Case Management Agency
251B00000X [38004193]
4.3e-01
3.8e-01
6.5e-01
3.0e+00
8.8e-01
4.0e-01
2.9e-01
cases:54.13%
controls:43.39%
cases:46.28%
controls:37.15%
cases:22.52%
controls:13.13%
cases:13.43%
controls:0.77%
cases:26.40%
controls:12.95%
cases:51.49%
controls:41.63%
cases:71.00%
controls:64.75%
262
2098
222
2737
224
1796
260
3039
109
635
375
4200
65
37
419
4798
127
626
354
4209
242
2003
228
2809
311
2947
127
1604
Erythrocytes [#/volume] in Urine
30391-7 [3002582]
4.7e-01
1.1e+00
1.7e+00
—
2.5e+00
1.3e+00
8.1e-01
cases:3.51%
controls:2.23%
cases:3.10%
controls:1.05%
cases:1.03%
controls:0.19%
—
—
cases:1.46%
controls:0.12%
cases:4.26%
controls:1.14%
cases:11.42%
controls:5.43%
17
108
467
4727
15
51
469
4784
5
9
479
4826
—
7
6
474
4829
20
55
450
4757
50
247
388
4304
Immunohistochemistry procedure
117617002 [4035726]
—
2.2e+00
—
—
—
1.9e+00
1.6e+00
—
—
cases:1.65%
controls:0.19%
—
—
—
—
—
—
cases:1.70%
controls:0.27%
cases:3.42%
controls:0.68%
—
8
9
476
4826
—
—
—
8
13
462
4799
15
31
423
4520
Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
14804-9 [3022250]
2.5e-01
2.1e+00
—
—
—
2.2e+00
1.4e+00
cases:1.03%
controls:0.81%
cases:2.27%
controls:0.29%
—
—
—
—
—
—
cases:2.98%
controls:0.35%
cases:5.02%
controls:1.32%
5
39
479
4796
11
14
473
4821
—
—
—
14
17
456
4795
22
60
416
4491
calcium (different salts in combination); oral
A12AA20 [21600872]
5.4e-01
7.6e-01
9.3e-01
—
1.5e+00
1.3e+00
1.3e+00
cases:11.16%
controls:6.80%
cases:10.74%
controls:5.34%
cases:3.10%
controls:1.24%
—
—
cases:5.20%
controls:1.24%
cases:18.72%
controls:5.94%
cases:28.31%
controls:9.36%
54
329
430
4506
52
258
432
4577
15
60
469
4775
—
25
60
456
4775
88
286
382
4526
124
426
314
4125
Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]
1.5e-01
6.1e-01
1.9e+00
—
1.9e+00
5.9e-01
3.7e-01
cases:16.74%
controls:14.73%
cases:18.18%
controls:10.80%
cases:12.81%
controls:2.19%
—
—
cases:11.23%
controls:1.80%
cases:21.70%
controls:13.30%
cases:40.41%
controls:31.99%
81
712
403
4123
88
522
396
4313
62
106
422
4729
—
54
87
427
4748
102
640
368
4172
177
1456
261
3095
Bacteria [#/volume] in Urine by Automated count
51480-2 [3031040]
3.3e-01
8.6e-01
2.1e+00
1.0e+50
1.8e+00
6.1e-01
5.6e-01
cases:8.88%
controls:6.54%
cases:7.44%
controls:3.29%
cases:3.72%
controls:0.48%
cases:1.03%
controls:0.00%
cases:2.49%
controls:0.41%
cases:7.23%
controls:4.05%
cases:21.46%
controls:13.54%
43
316
441
4519
36
159
448
4676
18
23
466
4812
5
0
479
4835
12
20
469
4815
34
195
436
4617
94
616
344
3935
Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]
1.4e-01
6.2e-01
1.8e+00
—
1.9e+00
6.0e-01
3.6e-01
cases:16.74%
controls:14.85%
cases:18.60%
controls:10.94%
cases:12.40%
controls:2.21%
—
—
cases:11.02%
controls:1.80%
cases:22.34%
controls:13.61%
cases:40.41%
controls:32.21%
81
718
403
4117
90
529
394
4306
60
107
424
4728
—
53
87
428
4748
105
655
365
4157
177
1466
261
3085
Urinalysis macro (dipstick) panel - Urine
24357-6 [3037467]
4.6e-01
6.5e-01
2.0e+00
—
2.0e+00
7.2e-01
5.5e-01
cases:10.54%
controls:6.91%
cases:6.82%
controls:3.68%
cases:3.93%
controls:0.54%
—
—
cases:2.91%
controls:0.39%
cases:8.30%
controls:4.22%
cases:22.37%
controls:14.26%
51
334
433
4501
33
178
451
4657
19
26
465
4809
—
14
19
467
4816
39
203
431
4609
98
649
340
3902
Medical doctor
Z2221 [2001311556]
7.6e-01
1.4e+00
—
1.0e+50
—
1.6e+00
1.5e+00
cases:8.06%
controls:3.93%
cases:5.99%
controls:1.55%
—
—
cases:1.24%
controls:0.00%
—
—
cases:7.23%
controls:1.52%
cases:13.93%
controls:3.58%
39
190
445
4645
29
75
455
4760
—
6
0
478
4835
—
34
73
436
4739
61
163
377
4388
Type 2 diabetes mellitus, without complications
E11.9 [45561952]
5.6e-01
1.2e+00
—
1.0e+50
2.1e+00
1.3e+00
6.5e-01
cases:5.37%
controls:3.14%
cases:5.17%
controls:1.61%
—
—
cases:1.03%
controls:0.00%
cases:2.29%
controls:0.29%
cases:6.17%
controls:1.81%
cases:9.59%
controls:5.23%
26
152
458
4683
25
78
459
4757
—
5
0
479
4835
11
14
470
4821
29
87
441
4725
42
238
396
4313
Leukocytes [#/volume] in Urine
30405-5 [3018095]
3.3e-01
1.0e+00
1.5e+00
—
2.3e+00
1.1e+00
6.8e-01
cases:3.51%
controls:2.54%
cases:3.51%
controls:1.28%
cases:1.24%
controls:0.29%
—
—
cases:1.66%
controls:0.17%
cases:4.26%
controls:1.43%
cases:11.87%
controls:6.37%
17
123
467
4712
17
62
467
4773
6
14
478
4821
—
8
8
473
4827
20
69
450
4743
52
290
386
4261
Office Visit
OMOP4822458 [581477]
4.7e-01
1.1e+00
1.5e+00
1.0e+50
2.1e+00
1.0e+00
8.4e-01
cases:12.40%
controls:8.15%
cases:8.26%
controls:2.81%
cases:1.65%
controls:0.37%
cases:2.07%
controls:0.00%
cases:3.33%
controls:0.41%
cases:6.38%
controls:2.41%
cases:16.89%
controls:8.04%
60
394
424
4441
40
136
444
4699
8
18
476
4817
10
0
474
4835
16
20
465
4815
30
116
440
4696
74
366
364
4185
Clinical & Laboratory Dermatological Immunology Physician
207NI0002X [38003841]
4.7e-01
9.8e-01
2.0e+00
—
1.5e+00
1.3e+00
8.3e-01
cases:8.88%
controls:5.75%
cases:5.99%
controls:2.34%
cases:2.07%
controls:0.29%
—
—
cases:1.66%
controls:0.39%
cases:8.72%
controls:2.58%
cases:14.61%
controls:6.97%
43
278
441
4557
29
113
455
4722
10
14
474
4821
—
8
19
473
4816
41
124
429
4688
64
317
374
4234
Leukocyte esterase [Presence] in Urine by Automated test strip
60026-2 [40763086]
2.5e-01
5.9e-01
2.2e+00
—
2.0e+00
8.2e-01
1.2e-01
cases:4.75%
controls:3.74%
cases:3.93%
controls:2.21%
cases:2.07%
controls:0.23%
—
—
cases:1.25%
controls:0.17%
cases:4.89%
controls:2.22%
cases:10.50%
controls:9.43%
23
181
461
4654
19
107
465
4728
10
11
474
4824
—
6
8
475
4827
23
107
447
4705
46
429
392
4122
Forced vital capacity [Volume] Respiratory system
19870-5 [3020158]
1.1e+00
2.1e+00
—
—
—
1.6e+00
1.8e+00
cases:3.31%
controls:1.14%
cases:1.65%
controls:0.21%
—
—
—
—
—
—
cases:1.49%
controls:0.29%
cases:3.88%
controls:0.64%
16
55
468
4780
8
10
476
4825
—
—
—
7
14
463
4798
17
29
421
4522
FEV1/FVC
19926-5 [3011505]
1.1e+00
2.1e+00
—
—
—
1.6e+00
1.8e+00
cases:3.31%
controls:1.14%
cases:1.65%
controls:0.21%
—
—
—
—
—
—
cases:1.49%
controls:0.29%
cases:3.88%
controls:0.64%
16
55
468
4780
8
10
476
4825
—
—
—
7
14
463
4798
17
29
421
4522
FEV1
20150-9 [3024653]
1.1e+00
2.1e+00
—
—
—
1.6e+00
1.8e+00
cases:3.31%
controls:1.14%
cases:1.65%
controls:0.21%
—
—
—
—
—
—
cases:1.49%
controls:0.29%
cases:3.88%
controls:0.64%
16
55
468
4780
8
10
476
4825
—
—
—
7
14
463
4798
17
29
421
4522
Supplier / Service Provider
OMOP5117446 [33004]
-1.2e+00
-4.6e-01
—
—
—
2.9e+00
3.3e+00
cases:9.71%
controls:25.67%
cases:4.55%
controls:7.01%
—
—
—
—
—
—
cases:5.11%
controls:0.29%
cases:14.38%
controls:0.64%
47
1241
437
3594
22
339
462
4496
—
—
—
24
14
446
4798
63
29
375
4522
Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
1825-9 [3026285]
2.5e+00
—
1.0e+50
—
1.0e+50
—
2.5e+00
cases:1.24%
controls:0.10%
—
—
cases:3.51%
controls:0.00%
—
—
cases:1.46%
controls:0.00%
—
—
cases:2.05%
controls:0.18%
6
5
478
4830
—
17
0
467
4835
—
7
0
474
4835
—
9
8
429
4543
Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]
2.2e-01
5.5e-01
2.0e+00
—
1.8e+00
5.6e-01
3.1e-01
cases:19.21%
controls:16.01%
cases:20.66%
controls:13.07%
cases:17.56%
controls:2.75%
—
—
cases:13.72%
controls:2.50%
cases:24.89%
controls:15.90%
cases:42.69%
controls:35.25%
93
774
391
4061
100
632
384
4203
85
133
399
4702
—
66
121
415
4714
117
765
353
4047
187
1604
251
2947
Fatty (change of) liver, not elsewhere classified
K76.0 [45601189]
2.5e+00
—
—
1.0e+50
1.0e+50
1.0e+50
2.4e+00
cases:1.45%
controls:0.12%
—
—
—
—
cases:1.45%
controls:0.00%
cases:2.08%
controls:0.00%
cases:4.47%
controls:0.00%
cases:2.97%
controls:0.26%
7
6
477
4829
—
—
7
0
477
4835
10
0
471
4835
21
0
449
4812
13
12
425
4539
Ammonium ion [Moles/volume] in Plasma
1845-7 [3023183]
—
—
—
—
1.0e+50
2.7e+00
2.2e+00
—
—
—
—
—
—
—
—
cases:3.12%
controls:0.00%
cases:1.49%
controls:0.10%
cases:2.97%
controls:0.33%
—
—
—
—
15
0
466
4835
7
5
463
4807
13
15
425
4536
cefalexin; oral
J01DB01 [21602870]
3.6e-01
8.5e-01
1.0e+00
—
1.4e+00
6.2e-01
5.7e-01
cases:35.12%
controls:27.32%
cases:18.39%
controls:8.75%
cases:2.89%
controls:1.03%
—
—
cases:3.33%
controls:0.87%
cases:14.47%
controls:8.37%
cases:40.41%
controls:27.77%
170
1321
314
3514
89
423
395
4412
14
50
470
4785
—
16
42
465
4793
68
403
402
4409
177
1264
261
3287
Abdominal ultrasound examination
JN3AE [2001305555]
7.5e-01
2.7e+00
—
1.0e+50
—
1.4e+00
2.1e+00
cases:1.86%
controls:0.89%
cases:4.13%
controls:0.29%
—
—
cases:2.89%
controls:0.00%
—
—
cases:1.49%
controls:0.37%
cases:7.31%
controls:0.94%
9
43
475
4792
20
14
464
4821
—
14
0
470
4835
—
7
18
463
4794
32
43
406
4508
Troponin T.cardiac [Mass/volume] in Serum or Plasma
6598-7 [3019800]
1.8e-01
1.3e+00
2.3e+00
1.0e+50
—
1.1e+00
4.8e-01
cases:3.31%
controls:2.77%
cases:4.55%
controls:1.30%
cases:1.65%
controls:0.17%
cases:1.03%
controls:0.00%
—
—
cases:4.68%
controls:1.68%
cases:11.19%
controls:7.23%
16
134
468
4701
22
63
462
4772
8
8
476
4827
5
0
479
4835
—
22
81
448
4731
49
329
389
4222
Ketones [Presence] in Urine by Test strip
2514-8 [3035350]
2.6e-01
6.6e-01
1.9e+00
—
2.0e+00
7.5e-01
8.8e-02
cases:5.37%
controls:4.20%
cases:4.75%
controls:2.52%
cases:2.27%
controls:0.35%
—
—
cases:1.46%
controls:0.21%
cases:5.53%
controls:2.68%
cases:12.56%
controls:11.62%
26
203
458
4632
23
122
461
4713
11
17
473
4818
—
7
10
474
4825
26
129
444
4683
55
529
383
4022
Result test/procedure
-60 [2002000131]
—
—
—
—
—
2.3e+00
2.2e+00
—
—
—
—
—
—
—
—
—
—
cases:1.28%
controls:0.12%
cases:2.05%
controls:0.24%
—
—
—
—
—
6
6
464
4806
9
11
429
4540
Other specified special examinations
Z01.8 [45581003]
5.7e-01
1.8e+00
—
—
—
1.5e+00
1.1e+00
cases:3.31%
controls:1.90%
cases:3.10%
controls:0.52%
—
—
—
—
—
—
cases:3.40%
controls:0.81%
cases:7.76%
controls:2.64%
16
92
468
4743
15
25
469
4810
—
—
—
16
39
454
4773
34
120
404
4431
Rheumatology
66 [38004491]
9.0e-01
9.7e-01
—
—
—
1.2e+00
1.3e+00
cases:5.58%
controls:2.34%
cases:4.13%
controls:1.61%
—
—
—
—
—
—
cases:4.89%
controls:1.50%
cases:10.27%
controls:3.03%
27
113
457
4722
20
78
464
4757
—
—
—
23
72
447
4740
45
138
393
4413
Reticulocytes [#/volume] in Blood
14196-0 [3023520]
—
1.9e+00
—
—
—
2.3e+00
9.5e-01
—
—
cases:1.45%
controls:0.23%
—
—
—
—
—
—
cases:2.34%
controls:0.23%
cases:2.51%
controls:0.99%
—
7
11
477
4824
—
—
—
11
11
459
4801
11
45
427
4506
ciprofloxacin; oral, parenteral
J01MA02 [21603009]
7.1e-01
7.9e-01
—
—
2.7e+00
7.9e-01
7.4e-01
cases:10.33%
controls:5.34%
cases:3.72%
controls:1.72%
—
—
—
—
cases:1.87%
controls:0.12%
cases:3.40%
controls:1.58%
cases:11.19%
controls:5.69%
50
258
434
4577
18
83
466
4752
—
—
9
6
472
4829
16
76
454
4736
49
259
389
4292
MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 [3003338]
7.9e-02
3.7e-01
1.8e+00
—
1.8e+00
4.7e-01
2.3e-02
cases:14.26%
controls:13.32%
cases:14.88%
controls:10.78%
cases:12.19%
controls:2.19%
—
—
cases:11.64%
controls:2.05%
cases:18.51%
controls:12.45%
cases:29.91%
controls:29.42%
69
644
415
4191
72
521
412
4314
59
106
425
4729
—
56
99
425
4736
87
599
383
4213
131
1339
307
3212
One hour or less
ZXE00 [2001311394]
4.5e-01
5.2e-01
2.0e+00
—
1.8e+00
1.0e+00
1.1e+00
cases:8.26%
controls:5.42%
cases:2.69%
controls:1.61%
cases:1.45%
controls:0.21%
—
—
cases:1.04%
controls:0.17%
cases:3.62%
controls:1.33%
cases:13.24%
controls:4.61%
40
262
444
4573
13
78
471
4757
7
10
477
4825
—
5
8
476
4827
17
64
453
4748
58
210
380
4341
Biopsy of liver with ultrasound guidance
JJ2AT [2001305254]
—
—
1.0e+50
1.0e+50
1.0e+50
1.0e+50
4.1e+00
—
—
—
—
cases:2.69%
controls:0.00%
cases:3.72%
controls:0.00%
cases:4.16%
controls:0.00%
cases:4.68%
controls:0.00%
cases:7.53%
controls:0.13%
—
—
13
0
471
4835
18
0
466
4835
20
0
461
4835
22
0
448
4812
33
6
405
4545
Reticulocytes/Erythrocytes in Blood
4679-7 [3027945]
8.4e-01
2.1e+00
—
—
—
2.0e+00
8.4e-01
cases:1.24%
controls:0.54%
cases:2.27%
controls:0.29%
—
—
—
—
—
—
cases:2.77%
controls:0.37%
cases:3.65%
controls:1.60%
6
26
478
4809
11
14
473
4821
—
—
—
13
18
457
4794
16
73
422
4478
Hepatitis B virus core Ab [Presence] in Serum
16933-4 [3021879]
1.1e+00
2.8e+00
—
—
1.0e+50
—
1.3e+00
cases:1.86%
controls:0.64%
cases:3.31%
controls:0.21%
—
—
—
—
cases:1.25%
controls:0.00%
—
—
cases:2.51%
controls:0.70%
9
31
475
4804
16
10
468
4825
—
—
6
0
475
4835
—
11
32
427
4519
Urinalysis microscopic panel [#/volume] - Urine by Automated count
50554-5 [3029287]
2.7e-01
8.2e-01
—
—
2.2e+00
1.2e+00
6.5e-01
cases:3.72%
controls:2.87%
cases:3.10%
controls:1.39%
—
—
—
—
cases:1.66%
controls:0.19%
cases:4.26%
controls:1.29%
cases:11.64%
controls:6.44%
18
139
466
4696
15
67
469
4768
—
—
8
9
473
4826
20
62
450
4750
51
293
387
4258
Arthritis, unspecified
M13.9 [45567463]
1.2e+00
2.0e+00
—
—
—
2.0e+00
1.3e+00
cases:1.65%
controls:0.50%
cases:1.24%
controls:0.17%
—
—
—
—
—
—
cases:1.28%
controls:0.17%
cases:2.28%
controls:0.62%
8
24
476
4811
6
8
478
4827
—
—
—
6
8
464
4804
10
28
428
4523
ABO and Rh group [Type] in Blood by Confirmatory method
77397-8 [46236098]
8.7e-01
1.4e+00
—
—
1.0e+50
1.4e+00
1.2e+00
cases:2.69%
controls:1.14%
cases:2.48%
controls:0.64%
—
—
—
—
cases:1.25%
controls:0.00%
cases:3.19%
controls:0.77%
cases:8.90%
controls:2.75%
13
55
471
4780
12
31
472
4804
—
—
6
0
475
4835
15
37
455
4775
39
125
399
4426
Flexible sigmoidoscopy with biopsy
UJF45 [2001305031]
—
—
—
—
—
2.2e+00
1.9e+00
—
—
—
—
—
—
—
—
—
—
cases:1.28%
controls:0.15%
cases:3.20%
controls:0.51%
—
—
—
—
—
6
7
464
4805
14
23
424
4528
Haptoglobin [Mass/volume] in Serum or Plasma
4542-7 [3012336]
—
—
—
—
—
2.3e+00
1.7e+00
—
—
—
—
—
—
—
—
—
—
cases:1.28%
controls:0.12%
cases:2.97%
controls:0.55%
—
—
—
—
—
6
6
464
4806
13
25
425
4526
levofloxacin; inhalant, oral, parenteral
J01MA12 [21603019]
1.3e+00
1.0e+00
—
—
—
1.7e+00
9.5e-01
cases:5.37%
controls:1.49%
cases:1.45%
controls:0.52%
—
—
—
—
—
—
cases:2.34%
controls:0.42%
cases:5.94%
controls:2.37%
26
72
458
4763
7
25
477
4810
—
—
—
11
20
459
4792
26
108
412
4443
Magnesium [Moles/volume] in Serum or Plasma
2601-3 [3012095]
1.1e-01
1.6e+00
—
—
—
1.5e+00
9.4e-01
cases:1.24%
controls:1.12%
cases:1.86%
controls:0.39%
—
—
—
—
—
—
cases:2.34%
controls:0.54%
cases:5.94%
controls:2.40%
6
54
478
4781
9
19
475
4816
—
—
—
11
26
459
4786
26
109
412
4442
Inpatient Visit
IP [9201]
6.0e-01
1.1e+00
—
—
2.7e+00
1.3e+00
5.9e-01
cases:3.93%
controls:2.19%
cases:2.69%
controls:0.95%
—
—
—
—
cases:1.46%
controls:0.10%
cases:3.40%
controls:0.94%
cases:7.53%
controls:4.33%
19
106
465
4729
13
46
471
4789
—
—
7
5
474
4830
16
45
454
4767
33
197
405
4354
Metamyelocytes/Leukocytes in Blood
28541-1 [3002179]
—
1.6e+00
—
—
—
2.2e+00
1.7e+00
—
—
cases:1.03%
controls:0.21%
—
—
—
—
—
—
cases:3.19%
controls:0.35%
cases:4.57%
controls:0.86%
—
5
10
479
4825
—
—
—
15
17
455
4795
20
39
418
4512
oxycodone; oral, parenteral
N02AA05 [21604260]
1.2e+00
1.6e+00
—
—
2.3e+00
2.4e+00
7.9e-01
cases:1.86%
controls:0.58%
cases:1.86%
controls:0.39%
—
—
—
—
cases:1.04%
controls:0.10%
cases:3.19%
controls:0.31%
cases:4.57%
controls:2.13%
9
28
475
4807
9
19
475
4816
—
—
5
5
476
4830
15
15
455
4797
20
97
418
4454
Blood type and Crossmatch panel - Blood
34531-4 [3044640]
4.4e-01
1.4e+00
—
—
—
1.5e+00
1.0e+00
cases:3.10%
controls:2.03%
cases:3.93%
controls:1.01%
—
—
—
—
—
—
cases:4.04%
controls:0.94%
cases:10.96%
controls:4.17%
15
98
469
4737
19
49
465
4786
—
—
—
19
45
451
4767
48
190
390
4361
Essential (primary) hypertension
I10 [45591453]
3.5e-01
7.9e-01
1.0e+00
—
1.6e+00
9.5e-01
6.1e-01
cases:15.08%
controls:11.11%
cases:11.16%
controls:5.40%
cases:2.69%
controls:0.97%
—
—
cases:3.74%
controls:0.81%
cases:14.04%
controls:5.96%
cases:27.85%
controls:17.31%
73
537
411
4298
54
261
430
4574
13
47
471
4788
—
18
39
463
4796
66
287
404
4525
122
788
316
3763
Cholangitis
K83.0 [45552955]
—
—
—
—
1.0e+50
—
3.9e+00
—
—
—
—
—
—
—
—
cases:1.04%
controls:0.00%
—
—
cases:6.16%
controls:0.13%
—
—
—
—
5
0
476
4835
—
27
6
411
4545
Nitrite [Presence] in Urine by Test strip
5802-4 [3021601]
3.0e-01
6.6e-01
2.0e+00
—
1.9e+00
7.5e-01
5.4e-02
cases:5.37%
controls:4.03%
cases:4.75%
controls:2.50%
cases:2.27%
controls:0.31%
—
—
cases:1.46%
controls:0.23%
cases:5.32%
controls:2.58%
cases:11.87%
controls:11.32%
26
195
458
4640
23
121
461
4714
11
15
473
4820
—
7
11
474
4824
25
124
445
4688
52
515
386
4036
Lumbar spine X-ray examination without contrast
NA3AA [2001307026]
—
2.3e+00
—
—
—
—
1.6e+00
—
—
cases:1.45%
controls:0.14%
—
—
—
—
—
—
—
—
cases:2.74%
controls:0.59%
—
7
7
477
4828
—
—
—
—
12
27
426
4524
Telephone, letter or other consultation without direct patient contact
ZY020 [2001311600]
1.5e+00
2.3e+00
—
—
—
—
1.1e+00
cases:2.27%
controls:0.50%
cases:1.24%
controls:0.12%
—
—
—
—
—
—
—
—
cases:1.83%
controls:0.64%
11
24
473
4811
6
6
478
4829
—
—
—
—
8
29
430
4522
Gastroscopy
UJD02 [2001304787]
1.7e+00
—
—
—
—
—
2.1e+00
cases:2.07%
controls:0.37%
—
—
—
—
—
—
—
—
—
—
cases:2.28%
controls:0.29%
10
18
474
4817
—
—
—
—
—
10
13
428
4538
Hematology
82 [38004501]
4.9e-01
1.2e+00
—
—
2.5e+00
1.1e+00
1.3e+00
cases:1.24%
controls:0.77%
cases:1.65%
controls:0.52%
—
—
—
—
cases:1.25%
controls:0.10%
cases:1.70%
controls:0.58%
cases:3.42%
controls:0.94%
6
37
478
4798
8
25
476
4810
—
—
6
5
475
4830
8
28
462
4784
15
43
423
4508
Glucose [Presence] in Urine by Test strip
25428-4 [3009261]
2.2e-01
6.1e-01
1.9e+00
—
1.9e+00
7.0e-01
6.5e-02
cases:5.17%
controls:4.20%
cases:4.75%
controls:2.65%
cases:2.27%
controls:0.33%
—
—
cases:1.46%
controls:0.23%
cases:5.32%
controls:2.70%
cases:12.33%
controls:11.65%
25
203
459
4632
23
128
461
4707
11
16
473
4819
—
7
11
474
4824
25
130
445
4682
54
530
384
4021
Promyelocytes/Leukocytes in Blood
26524-9 [3021440]
—
1.4e+00
2.3e+00
—
—
2.1e+00
1.7e+00
—
—
cases:1.03%
controls:0.27%
cases:1.03%
controls:0.10%
—
—
—
—
cases:3.19%
controls:0.39%
cases:4.57%
controls:0.90%
—
5
13
479
4822
5
5
479
4830
—
—
15
19
455
4793
20
41
418
4510
Myelocytes/Leukocytes in Blood
26498-6 [3017181]
—
1.4e+00
2.3e+00
—
—
2.2e+00
1.5e+00
—
—
cases:1.03%
controls:0.27%
cases:1.03%
controls:0.10%
—
—
—
—
cases:3.62%
controls:0.39%
cases:4.57%
controls:1.03%
—
5
13
479
4822
5
5
479
4830
—
—
17
19
453
4793
20
47
418
4504
Blasts/Leukocytes in Blood
26446-5 [3025159]
—
1.4e+00
—
—
—
2.2e+00
1.5e+00
—
—
cases:1.03%
controls:0.25%
—
—
—
—
—
—
cases:3.40%
controls:0.37%
cases:3.65%
controls:0.83%
—
5
12
479
4823
—
—
—
16
18
454
4794
16
38
422
4513
Coeliac disease
K90.0 [45586745]
1.0e+00
1.9e+00
—
1.0e+50
—
1.9e+00
1.4e+00
cases:1.24%
controls:0.46%
cases:1.45%
controls:0.23%
—
—
cases:1.03%
controls:0.00%
—
—
cases:1.70%
controls:0.27%
cases:1.60%
controls:0.42%
6
22
478
4813
7
11
477
4824
—
5
0
479
4835
—
8
13
462
4799
7
19
431
4532
Spinal stenosis
M48.0 [45557888]
9.7e-01
1.2e+00
2.7e+00
—
—
1.4e+00
1.0e+00
cases:2.48%
controls:0.95%
cases:1.45%
controls:0.43%
cases:1.45%
controls:0.10%
—
—
—
—
cases:1.70%
controls:0.44%
cases:4.57%
controls:1.69%
12
46
472
4789
7
21
477
4814
7
5
477
4830
—
—
8
21
462
4791
20
77
418
4474
Casts [#/volume] in Urine by Automated count
51483-6 [3030467]
4.4e-01
1.3e+00
—
—
—
1.4e+00
9.3e-01
cases:2.89%
controls:1.88%
cases:2.89%
controls:0.81%
—
—
—
—
—
—
cases:3.83%
controls:0.94%
cases:10.27%
controls:4.31%
14
91
470
4744
14
39
470
4796
—
—
—
18
45
452
4767
45
196
393
4355
Chronic ulcer skin
S97 [2002001061]
1.6e+00
—
—
—
—
2.2e+00
1.4e+00
cases:1.24%
controls:0.25%
—
—
—
—
—
—
—
—
cases:1.49%
controls:0.17%
cases:2.51%
controls:0.62%
6
12
478
4823
—
—
—
—
7
8
463
4804
11
28
427
4523
Examination and observation for other specified reasons
Z04.8 [45552063]
8.1e-01
—
—
—
—
2.2e+00
1.4e+00
cases:2.48%
controls:1.12%
—
—
—
—
—
—
—
—
cases:2.55%
controls:0.29%
cases:4.79%
controls:1.21%
12
54
472
4781
—
—
—
—
12
14
458
4798
21
55
417
4496
temazepam; oral
N05CD07 [21604642]
7.4e-01
3.2e-01
7.0e-01
—
1.9e+00
8.8e-01
8.6e-01
cases:5.17%
controls:2.54%
cases:2.27%
controls:1.65%
cases:1.03%
controls:0.52%
—
—
cases:2.08%
controls:0.33%
cases:4.04%
controls:1.72%
cases:6.62%
controls:2.90%
25
123
459
4712
11
80
473
4755
5
25
479
4810
—
10
16
471
4819
19
83
451
4729
29
132
409
4419
Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
19176-7 [3015916]
—
—
—
—
—
—
3.6e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:5.25%
controls:0.15%
—
—
—
—
—
—
23
7
415
4544
Erythrocytes [Presence] in Urine by Automated
53292-9 [3041096]
1.8e-01
5.2e-01
2.6e+00
—
—
9.3e-01
2.2e-01
cases:2.89%
controls:2.42%
cases:2.48%
controls:1.49%
cases:1.65%
controls:0.12%
—
—
—
—
cases:3.62%
controls:1.45%
cases:7.31%
controls:5.98%
14
117
470
4718
12
72
472
4763
8
6
476
4829
—
—
17
70
453
4742
32
272
406
4279
combinations of corticosteroids
D07XB30 [21602188]
4.1e-01
9.8e-01
1.8e+00
—
-1.0e+50
8.0e-01
3.1e-01
cases:13.43%
controls:9.37%
cases:8.26%
controls:3.27%
cases:1.65%
controls:0.29%
—
—
cases:0.00%
controls:0.64%
cases:7.66%
controls:3.60%
cases:14.16%
controls:10.79%
65
453
419
4382
40
158
444
4677
8
14
476
4821
—
0
31
481
4804
36
173
434
4639
62
491
376
4060
combinations of corticosteroids
D07AB30 [21602118]
4.1e-01
9.8e-01
1.8e+00
—
-1.0e+50
8.0e-01
3.1e-01
cases:13.43%
controls:9.37%
cases:8.26%
controls:3.27%
cases:1.65%
controls:0.29%
—
—
cases:0.00%
controls:0.64%
cases:7.66%
controls:3.60%
cases:14.16%
controls:10.79%
65
453
419
4382
40
158
444
4677
8
14
476
4821
—
0
31
481
4804
36
173
434
4639
62
491
376
4060
Urea [Moles/volume] in Serum or Plasma
22664-7 [3020779]
—
1.5e+00
—
—
—
1.9e+00
1.6e+00
—
—
cases:1.24%
controls:0.29%
—
—
—
—
—
—
cases:2.34%
controls:0.37%
cases:4.79%
controls:0.97%
—
6
14
478
4821
—
—
—
11
18
459
4794
21
44
417
4507
Liver disease, unspecified
K76.9 [45572233]
—
—
1.0e+50
—
1.0e+50
1.0e+50
3.4e+00
—
—
—
—
cases:3.51%
controls:0.00%
—
—
cases:2.29%
controls:0.00%
cases:5.32%
controls:0.00%
cases:3.20%
controls:0.11%
—
—
17
0
467
4835
—
11
0
470
4835
25
0
445
4812
14
5
424
4546
Periodontitis pronounced
K05.31 [2000502729]
1.7e-01
2.2e+00
—
—
—
—
1.2e+00
cases:1.03%
controls:0.87%
cases:1.24%
controls:0.14%
—
—
—
—
—
—
—
—
cases:3.42%
controls:1.03%
5
42
479
4793
6
7
478
4828
—
—
—
—
15
47
423
4504
Extensive abdominal CT
JN3BD [2001305556]
—
1.9e+00
—
1.0e+50
—
2.0e+00
1.4e+00
—
—
cases:1.86%
controls:0.27%
—
—
cases:1.03%
controls:0.00%
—
—
cases:1.06%
controls:0.15%
cases:2.74%
controls:0.68%
—
9
13
475
4822
—
5
0
479
4835
—
5
7
465
4805
12
31
426
4520
Mental and behavioural disorders due to use of alcohol, Harmful use
F10.1 [45595844]
1.2e+00
1.4e+00
—
—
—
1.9e+00
1.5e+00
cases:1.86%
controls:0.56%
cases:1.24%
controls:0.31%
—
—
—
—
—
—
cases:2.13%
controls:0.33%
cases:2.97%
controls:0.70%
9
27
475
4808
6
15
478
4820
—
—
—
10
16
460
4796
13
32
425
4519
Other transduodenal endoscopic operation on bile duct or ampulla of Vater
JKE98 [2001305336]
—
—
—
—
—
—
3.3e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.97%
controls:0.11%
—
—
—
—
—
—
13
5
425
4546
Blood group antibody screen [Presence] in Serum or Plasma
890-4 [3001079]
1.8e-01
1.3e+00
—
—
—
1.3e+00
6.5e-01
cases:3.93%
controls:3.31%
cases:5.37%
controls:1.55%
—
—
—
—
—
—
cases:5.32%
controls:1.45%
cases:12.56%
controls:6.94%
19
160
465
4675
26
75
458
4760
—
—
—
25
70
445
4742
55
316
383
4235
Cortisol [Moles/volume] in Serum or Plasma
14675-3 [3036481]
—
—
—
—
—
2.0e+00
1.3e+00
—
—
—
—
—
—
—
—
—
—
cases:2.98%
controls:0.42%
cases:4.79%
controls:1.38%
—
—
—
—
—
14
20
456
4792
21
63
417
4488
Ultrasound elastography of liver
JJ1LE [2001305253]
—
—
—
—
—
1.0e+50
3.2e+00
—
—
—
—
—
—
—
—
—
—
cases:1.06%
controls:0.00%
cases:2.74%
controls:0.11%
—
—
—
—
—
5
0
465
4812
12
5
426
4546
Alcoholic cirrhosis of liver
K70.3 [45596343]
—
—
—
—
1.0e+50
—
3.2e+00
—
—
—
—
—
—
—
—
cases:1.25%
controls:0.00%
—
—
cases:3.20%
controls:0.13%
—
—
—
—
6
0
475
4835
—
14
6
424
4545
Dyspnoea
R06.0 [45558449]
1.1e+00
7.5e-01
—
—
—
1.2e+00
8.8e-01
cases:5.79%
controls:2.05%
cases:1.65%
controls:0.79%
—
—
—
—
—
—
cases:2.55%
controls:0.75%
cases:7.53%
controls:3.27%
28
99
456
4736
8
38
476
4797
—
—
—
12
36
458
4776
33
149
405
4402
Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
9838-4 [3003265]
—
—
—
—
—
—
3.1e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:3.42%
controls:0.15%
—
—
—
—
—
—
15
7
423
4544
Tissue Pathology biopsy report
66121-5 [40768804]
-1.3e-01
6.4e-01
—
—
2.4e+00
8.0e-01
6.9e-01
cases:3.10%
controls:3.52%
cases:2.89%
controls:1.55%
—
—
—
—
cases:2.08%
controls:0.19%
cases:3.19%
controls:1.45%
cases:10.96%
controls:5.80%
15
170
469
4665
14
75
470
4760
—
—
10
9
471
4826
15
70
455
4742
48
264
390
4287
25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
68438-1 [40771025]
3.6e-01
8.7e-01
1.5e+00
—
1.8e+00
1.2e+00
9.9e-01
cases:4.75%
controls:3.35%
cases:4.13%
controls:1.78%
cases:1.24%
controls:0.27%
—
—
cases:1.25%
controls:0.21%
cases:6.81%
controls:2.18%
cases:18.95%
controls:8.02%
23
162
461
4673
20
86
464
4749
6
13
478
4822
—
6
10
475
4825
32
105
438
4707
83
365
355
4186
HIV 1 and 2 tests - Meaningful Use set
75622-1 [46235355]
4.4e-01
1.4e+00
—
—
—
1.6e+00
3.5e-01
cases:2.27%
controls:1.47%
cases:2.27%
controls:0.58%
—
—
—
—
—
—
cases:1.91%
controls:0.37%
cases:3.65%
controls:2.61%
11
71
473
4764
11
28
473
4807
—
—
—
9
18
461
4794
16
119
422
4432
Forced vital capacity [Volume] Respiratory system --post bronchodilation
19875-4 [3001668]
1.1e+00
1.9e+00
—
—
—
1.5e+00
1.9e+00
cases:2.89%
controls:1.01%
cases:1.24%
controls:0.19%
—
—
—
—
—
—
cases:1.06%
controls:0.23%
cases:3.65%
controls:0.55%
14
49
470
4786
6
9
478
4826
—
—
—
5
11
465
4801
16
25
422
4526
FEV1/FVC --post bronchodilation
69970-2 [42868459]
1.1e+00
1.9e+00
—
—
—
1.5e+00
1.9e+00
cases:2.89%
controls:1.01%
cases:1.24%
controls:0.19%
—
—
—
—
—
—
cases:1.06%
controls:0.23%
cases:3.65%
controls:0.55%
14
49
470
4786
6
9
478
4826
—
—
—
5
11
465
4801
16
25
422
4526
FEV1 --post bronchodilation
20155-8 [3023550]
1.1e+00
1.9e+00
—
—
—
1.5e+00
1.9e+00
cases:2.89%
controls:1.01%
cases:1.24%
controls:0.19%
—
—
—
—
—
—
cases:1.06%
controls:0.23%
cases:3.65%
controls:0.55%
14
49
470
4786
6
9
478
4826
—
—
—
5
11
465
4801
16
25
422
4526
FEV1 percent change
69983-5 [42868472]
1.1e+00
1.9e+00
—
—
—
1.5e+00
1.9e+00
cases:2.89%
controls:1.01%
cases:1.24%
controls:0.19%
—
—
—
—
—
—
cases:1.06%
controls:0.23%
cases:3.65%
controls:0.55%
14
49
470
4786
6
9
478
4826
—
—
—
5
11
465
4801
16
25
422
4526
FVC percent change Respiratory system
69982-7 [42868471]
1.1e+00
1.9e+00
—
—
—
1.5e+00
1.9e+00
cases:2.89%
controls:1.01%
cases:1.24%
controls:0.19%
—
—
—
—
—
—
cases:1.06%
controls:0.23%
cases:3.65%
controls:0.55%
14
49
470
4786
6
9
478
4826
—
—
—
5
11
465
4801
16
25
422
4526
Bacteria identified in Isolate by Culture
43409-2 [3042936]
6.2e-01
1.8e+00
—
—
—
1.5e+00
1.4e+00
cases:1.45%
controls:0.79%
cases:1.24%
controls:0.21%
—
—
—
—
—
—
cases:1.91%
controls:0.42%
cases:6.85%
controls:1.76%
7
38
477
4797
6
10
478
4825
—
—
—
9
20
461
4792
30
80
408
4471
Hepatitis B virus core and surface Ab and surface Ag panel - Serum
77190-7 [46237023]
1.6e+00
2.9e+00
1.0e+50
—
—
—
1.5e+00
cases:1.45%
controls:0.31%
cases:2.69%
controls:0.14%
cases:1.65%
controls:0.00%
—
—
—
—
—
—
cases:1.37%
controls:0.31%
7
15
477
4820
13
7
471
4828
8
0
476
4835
—
—
—
6
14
432
4537
mycophenolic acid; oral, parenteral
L04AA06 [21603896]
—
—
—
—
—
—
2.9e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:4.11%
controls:0.24%
—
—
—
—
—
—
18
11
420
4540
pH of Venous blood
2746-6 [3012544]
—
2.1e+00
—
—
—
1.9e+00
9.8e-01
—
—
cases:1.03%
controls:0.12%
—
—
—
—
—
—
cases:1.49%
controls:0.23%
cases:3.65%
controls:1.41%
—
5
6
479
4829
—
—
—
7
11
463
4801
16
64
422
4487
Neurology
13 [38004458]
3.9e-01
8.4e-01
9.6e-01
—
1.4e+00
5.1e-01
5.7e-01
cases:12.19%
controls:8.60%
cases:7.85%
controls:3.56%
cases:1.65%
controls:0.64%
—
—
cases:2.29%
controls:0.56%
cases:5.96%
controls:3.68%
cases:15.53%
controls:9.45%
59
416
425
4419
38
172
446
4663
8
31
476
4804
—
11
27
470
4808
28
177
442
4635
68
430
370
4121
Other Crohn disease
K50.8 [45533599]
—
—
—
—
—
—
2.8e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.83%
controls:0.11%
—
—
—
—
—
—
8
5
430
4546
Base excess in Venous blood by calculation
1927-3 [3002032]
—
2.1e+00
—
—
—
1.8e+00
1.0e+00
—
—
cases:1.03%
controls:0.12%
—
—
—
—
—
—
cases:1.49%
controls:0.25%
cases:3.65%
controls:1.34%
—
5
6
479
4829
—
—
—
7
12
463
4800
16
61
422
4490
Elevated level of transaminase and lactic acid dehydrogenase
274774002 [436238]
—
—
1.0e+50
—
1.0e+50
1.0e+50
2.8e+00
—
—
—
—
cases:3.10%
controls:0.00%
—
—
cases:1.04%
controls:0.00%
cases:3.19%
controls:0.00%
cases:2.05%
controls:0.13%
—
—
15
0
469
4835
—
5
0
476
4835
15
0
455
4812
9
6
429
4545
Microscopic observation [Identifier] in Isolate by Gram stain
87975-9 [36305247]
—
—
—
—
—
—
2.7e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.28%
controls:0.15%
—
—
—
—
—
—
10
7
428
4544
omeprazole; oral, parenteral
A02BC01 [21600096]
5.4e-01
4.9e-01
1.1e+00
—
1.9e+00
6.5e-01
7.6e-01
cases:6.40%
controls:3.85%
cases:2.89%
controls:1.80%
cases:1.03%
controls:0.33%
—
—
cases:2.08%
controls:0.31%
cases:2.98%
controls:1.58%
cases:6.85%
controls:3.32%
31
186
453
4649
14
87
470
4748
5
16
479
4819
—
10
15
471
4820
14
76
456
4736
30
151
408
4400
Hemoglobin A1c/Hemoglobin.total in Blood
4548-4 [3004410]
5.1e-02
3.7e-01
1.5e+00
—
1.1e+00
1.8e-01
1.7e-01
cases:11.36%
controls:10.86%
cases:10.33%
controls:7.40%
cases:4.55%
controls:1.01%
—
—
cases:2.91%
controls:0.95%
cases:11.28%
controls:9.60%
cases:28.77%
controls:25.40%
55
525
429
4310
50
358
434
4477
22
49
462
4786
—
14
46
467
4789
53
462
417
4350
126
1156
312
3395
Phosphate [Moles/volume] in Serum or Plasma
14879-1 [3003458]
—
1.6e+00
2.3e+00
—
2.3e+00
1.1e+00
1.0e+00
—
—
cases:2.07%
controls:0.41%
cases:1.03%
controls:0.10%
—
—
cases:1.04%
controls:0.10%
cases:2.13%
controls:0.75%
cases:5.02%
controls:1.82%
—
10
20
474
4815
5
5
479
4830
—
5
5
476
4830
10
36
460
4776
22
83
416
4468
Thorax X-ray examination outside radiological department
GD1UA [2001303652]
-1.0e-03
1.5e+00
—
—
—
1.3e+00
1.1e+00
cases:1.24%
controls:1.24%
cases:1.86%
controls:0.41%
—
—
—
—
—
—
cases:1.28%
controls:0.35%
cases:4.34%
controls:1.43%
6
60
478
4775
9
20
475
4815
—
—
—
6
17
464
4795
19
65
419
4486
Pain localized to upper abdomen
R10.1 [45568111]
9.2e-01
1.8e+00
—
—
1.0e+50
1.4e+00
8.9e-01
cases:3.31%
controls:1.34%
cases:2.48%
controls:0.43%
—
—
—
—
cases:1.25%
controls:0.00%
cases:1.49%
controls:0.35%
cases:4.79%
controls:2.02%
16
65
468
4770
12
21
472
4814
—
—
6
0
475
4835
7
17
463
4795
21
92
417
4459
citalopram; oral, parenteral
N06AB04 [21604712]
7.8e-01
9.7e-01
7.8e-01
—
1.2e+00
9.0e-01
6.5e-01
cases:6.40%
controls:3.04%
cases:4.55%
controls:1.78%
cases:1.03%
controls:0.48%
—
—
cases:1.25%
controls:0.37%
cases:4.26%
controls:1.77%
cases:6.16%
controls:3.32%
31
147
453
4688
22
86
462
4749
5
23
479
4812
—
6
18
475
4817
20
85
450
4727
27
151
411
4400
Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
32785-8 [3043405]
—
—
—
—
—
—
2.6e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.83%
controls:0.13%
—
—
—
—
—
—
8
6
430
4545
Stomach Pathology biopsy report
66114-0 [40768797]
2.8e-01
1.3e+00
—
—
—
1.6e+00
1.0e+00
cases:1.45%
controls:1.10%
cases:1.45%
controls:0.39%
—
—
—
—
—
—
cases:2.34%
controls:0.48%
cases:4.57%
controls:1.69%
7
53
477
4782
7
19
477
4816
—
—
—
11
23
459
4789
20
77
418
4474
Extensive MRI examination of upper part of abdomen with high intensity magnet
JN1CG [2001305527]
—
—
—
—
—
—
2.6e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:3.20%
controls:0.24%
—
—
—
—
—
—
14
11
424
4540
Other extensive ultrasound examination of artery
PG1DE [2001309713]
—
—
—
—
—
—
2.6e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.28%
controls:0.18%
—
—
—
—
—
—
10
8
428
4543
alendronic acid; oral
M05BA04 [21604152]
4.7e-01
4.9e-01
-1.0e+50
—
—
1.2e+00
1.3e+00
cases:2.07%
controls:1.30%
cases:1.24%
controls:0.77%
cases:0.00%
controls:0.25%
—
—
—
—
cases:2.55%
controls:0.75%
cases:4.57%
controls:1.30%
10
63
474
4772
6
37
478
4798
0
12
484
4823
—
—
12
36
458
4776
20
59
418
4492
Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
47826-3 [3052649]
—
—
—
—
—
—
2.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.37%
controls:0.11%
—
—
—
—
—
—
6
5
432
4546
Gastritis, unspecified
K29.7 [45591583]
—
—
—
—
—
—
2.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.37%
controls:0.11%
—
—
—
—
—
—
6
5
432
4546
Bacteria [Presence] in Urine
87829-8 [36304419]
2.9e-01
1.1e+00
—
—
—
1.5e+00
1.0e+00
cases:2.48%
controls:1.86%
cases:2.27%
controls:0.77%
—
—
—
—
—
—
cases:3.83%
controls:0.89%
cases:10.05%
controls:3.80%
12
90
472
4745
11
37
473
4798
—
—
—
18
43
452
4769
44
173
394
4378
X-ray examination of the lungs in one projection
GD1PA [2001303645]
—
—
—
—
—
2.5e+00
1.0e+00
—
—
—
—
—
—
—
—
—
—
cases:1.28%
controls:0.10%
cases:2.28%
controls:0.81%
—
—
—
—
—
6
5
464
4807
10
37
428
4514
Cancer Ag 19-9 [Units/volume] in Serum or Plasma
24108-3 [3022914]
—
—
—
—
—
—
2.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:3.88%
controls:0.33%
—
—
—
—
—
—
17
15
421
4536
Dysuria/painful urination
U01 [2002001137]
—
2.5e+00
—
—
—
—
5.0e-01
—
—
cases:1.24%
controls:0.10%
—
—
—
—
—
—
—
—
cases:1.37%
controls:0.83%
—
6
5
478
4830
—
—
—
—
6
38
432
4513
Measurement of bone density from two or more locations with X-ray
NK6QA [2001308500]
1.4e+00
—
—
—
—
—
2.5e+00
cases:1.65%
controls:0.39%
—
—
—
—
—
—
—
—
—
—
cases:4.79%
controls:0.42%
8
19
476
4816
—
—
—
—
—
21
19
417
4532
ERCP
UJK02 [2001305365]
—
1.0e+50
—
—
—
—
2.5e+00
—
—
cases:1.03%
controls:0.00%
—
—
—
—
—
—
—
—
cases:2.05%
controls:0.18%
—
5
0
479
4835
—
—
—
—
9
8
429
4543
Foot and toes X-ray examination
NH3AA [2001308267]
6.7e-01
2.5e+00
—
—
—
—
1.0e+00
cases:1.24%
controls:0.64%
cases:1.45%
controls:0.12%
—
—
—
—
—
—
—
—
cases:2.05%
controls:0.77%
6
31
478
4804
7
6
477
4829
—
—
—
—
9
35
429
4516
Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
54067-4 [3051552]
1.2e+00
2.5e+00
—
—
—
—
6.7e-01
cases:1.24%
controls:0.39%
cases:1.45%
controls:0.12%
—
—
—
—
—
—
—
—
cases:1.83%
controls:0.94%
6
19
478
4816
7
6
477
4829
—
—
—
—
8
43
430
4508
hydrocortisone
S02BA01 [21605166]
1.8e-01
6.6e-01
2.5e+00
—
-1.0e+50
7.6e-01
2.5e-01
cases:5.99%
controls:5.05%
cases:3.10%
controls:1.63%
cases:1.45%
controls:0.12%
—
—
cases:0.00%
controls:0.17%
cases:4.04%
controls:1.93%
cases:8.45%
controls:6.72%
29
244
455
4591
15
79
469
4756
7
6
477
4829
—
0
8
481
4827
19
93
451
4719
37
306
401
4245
Epithelial cells [#/volume] in Urine
30383-4 [3000850]
2.5e-01
1.1e+00
—
—
—
1.6e+00
9.0e-01
cases:2.27%
controls:1.78%
cases:2.27%
controls:0.74%
—
—
—
—
—
—
cases:3.40%
controls:0.73%
cases:7.76%
controls:3.32%
11
86
473
4749
11
36
473
4799
—
—
—
16
35
454
4777
34
151
404
4400
oxazepam; oral
N05BA04 [21604569]
5.7e-01
7.7e-01
—
—
1.1e+00
8.8e-01
8.1e-01
cases:6.61%
controls:3.87%
cases:5.17%
controls:2.46%
—
—
—
—
cases:2.29%
controls:0.77%
cases:5.53%
controls:2.37%
cases:10.96%
controls:5.21%
32
187
452
4648
25
119
459
4716
—
—
11
37
470
4798
26
114
444
4698
48
237
390
4314
Laparoscopic cholecystectomy
JKA21 [2001305294]
9.7e-01
2.4e+00
—
—
—
1.7e+00
2.4e-01
cases:2.48%
controls:0.95%
cases:2.07%
controls:0.19%
—
—
—
—
—
—
cases:1.49%
controls:0.27%
cases:1.14%
controls:0.90%
12
46
472
4789
10
9
474
4826
—
—
—
7
13
463
4799
5
41
433
4510
Calculus of gallbladder without cholecystitis
K80.2 [45552951]
9.1e-01
2.4e+00
—
—
—
1.5e+00
9.5e-01
cases:2.69%
controls:1.10%
cases:2.27%
controls:0.21%
—
—
—
—
—
—
cases:1.70%
controls:0.39%
cases:2.51%
controls:0.99%
13
53
471
4782
11
10
473
4825
—
—
—
8
19
462
4793
11
45
427
4506
Myeloperoxidase IgG Ab [Units/volume] in Serum
48404-8 [3049804]
—
—
—
—
—
—
2.4e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.74%
controls:0.26%
—
—
—
—
—
—
12
12
426
4539
MRI examination of bile and pancreas ducts with high intesity magnet
JL5BG [2001305383]
—
—
—
—
—
—
2.4e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.05%
controls:0.20%
—
—
—
—
—
—
9
9
429
4542
Lysozyme [Mass/volume] in Serum or Plasma
2589-0 [3012110]
-1.0e+50
—
—
—
—
—
2.4e+00
cases:0.00%
controls:0.27%
—
—
—
—
—
—
—
—
—
—
cases:2.05%
controls:0.20%
0
13
484
4822
—
—
—
—
—
9
9
429
4542
High resolution CT examination of lungs
GD1DD [2001303632]
—
—
—
—
—
—
2.4e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.83%
controls:0.18%
—
—
—
—
—
—
8
8
430
4543
Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
66885-5 [40769539]
-1.0e+50
—
—
—
—
—
2.4e+00
cases:0.00%
controls:0.10%
—
—
—
—
—
—
—
—
—
—
cases:1.83%
controls:0.18%
0
5
484
4830
—
—
—
—
—
8
8
430
4543
Blood transfusion
WW500 [2001310603]
—
—
—
—
—
—
2.4e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.60%
controls:0.15%
—
—
—
—
—
—
7
7
431
4544
Shoulder extensive X-ray examination without contrast
NB1BA [2001307228]
-1.0e+50
—
—
—
—
—
2.4e+00
cases:0.00%
controls:0.10%
—
—
—
—
—
—
—
—
—
—
cases:1.37%
controls:0.13%
0
5
484
4830
—
—
—
—
—
6
6
432
4545
Lactate [Moles/volume] in Capillary blood
19239-3 [3028271]
—
—
—
—
—
—
2.4e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.14%
controls:0.11%
—
—
—
—
—
—
5
5
433
4546
Carbon dioxide [Partial pressure] in Blood
11557-6 [3013290]
—
—
—
—
—
—
2.4e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.14%
controls:0.11%
—
—
—
—
—
—
5
5
433
4546
Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
1778-0 [3020013]
—
—
—
—
—
—
2.4e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.14%
controls:0.11%
—
—
—
—
—
—
5
5
433
4546
Base excess in Blood by calculation
11555-0 [3012501]
—
—
—
—
—
—
2.4e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.14%
controls:0.11%
—
—
—
—
—
—
5
5
433
4546
Oxygen [Partial pressure] in Blood
11556-8 [3027315]
—
—
—
—
—
—
2.4e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.14%
controls:0.11%
—
—
—
—
—
—
5
5
433
4546
Other gastritis
K29.6 [45548154]
—
—
—
—
—
—
2.4e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.14%
controls:0.11%
—
—
—
—
—
—
5
5
433
4546
Biopsy of skin and subcutaneous tissue
TQX10 [2001310152]
5.1e-01
—
—
—
—
2.3e+00
9.3e-01
cases:1.24%
controls:0.74%
—
—
—
—
—
—
—
—
cases:1.70%
controls:0.17%
cases:1.83%
controls:0.73%
6
36
478
4799
—
—
—
—
8
8
462
4804
8
33
430
4518
Complement C3 [Mass/volume] in Serum or Plasma
4485-9 [3000620]
—
—
—
—
—
2.3e+00
—
—
—
—
—
—
—
—
—
—
—
cases:1.06%
controls:0.10%
—
—
—
—
—
—
—
5
5
465
4807
—
potassium chloride; oral
A12BA01 [21600877]
8.0e-01
1.1e+00
—
—
—
1.4e+00
9.5e-01
cases:2.27%
controls:1.03%
cases:2.07%
controls:0.68%
—
—
—
—
—
—
cases:2.55%
controls:0.67%
cases:5.02%
controls:2.00%
11
50
473
4785
10
33
474
4802
—
—
—
12
32
458
4780
22
91
416
4460
Gastro-oesophageal reflux disease with oesophagitis
K21.0 [45543296]
2.0e-01
2.3e+00
—
—
—
—
4.2e-01
cases:1.03%
controls:0.85%
cases:1.45%
controls:0.14%
—
—
—
—
—
—
—
—
cases:1.60%
controls:1.05%
5
41
479
4794
7
7
477
4828
—
—
—
—
7
48
431
4503
Osmolality of Urine
2695-5 [3026782]
1.2e-01
9.8e-01
2.0e+00
—
—
1.3e+00
9.8e-01
cases:2.07%
controls:1.84%
cases:1.86%
controls:0.70%
cases:1.03%
controls:0.14%
—
—
—
—
cases:2.98%
controls:0.81%
cases:7.99%
controls:3.16%
10
89
474
4746
9
34
475
4801
5
7
479
4828
—
—
14
39
456
4773
35
144
403
4407
IgG subclass 4 [Mass/volume] in Serum
2469-5 [3024980]
—
1.0e+50
—
—
—
—
2.3e+00
—
—
cases:1.03%
controls:0.00%
—
—
—
—
—
—
—
—
cases:2.51%
controls:0.26%
—
5
0
479
4835
—
—
—
—
11
12
427
4539
Hospital outpatient
ZY010 [2001311599]
—
—
—
—
—
—
2.2e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.60%
controls:0.18%
—
—
—
—
—
—
7
8
431
4543
Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
5159-9 [3007844]
—
—
1.0e+50
—
1.0e+50
—
2.2e+00
—
—
—
—
cases:1.24%
controls:0.00%
—
—
cases:1.25%
controls:0.00%
—
—
cases:1.60%
controls:0.18%
—
—
6
0
478
4835
—
6
0
475
4835
—
7
8
431
4543
Hemolysis interference index of Serum or Plasma
46424-8 [3052851]
—
—
—
—
—
—
2.2e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.37%
controls:0.15%
—
—
—
—
—
—
6
7
432
4544
Scheduled procedure
ZXD10 [2001311387]
4.4e-01
2.2e-01
—
—
—
1.1e+00
1.1e+00
cases:8.47%
controls:5.65%
cases:2.27%
controls:1.84%
—
—
—
—
—
—
cases:4.04%
controls:1.41%
cases:12.79%
controls:4.59%
41
273
443
4562
11
89
473
4746
—
—
—
19
68
451
4744
56
209
382
4342
Oncology Clinic/Center
261QX0200X [38004268]
-1.5e-02
7.4e-01
—
—
2.2e+00
3.6e-01
3.9e-01
cases:3.10%
controls:3.14%
cases:2.07%
controls:0.99%
—
—
—
—
cases:1.25%
controls:0.14%
cases:1.06%
controls:0.75%
cases:6.39%
controls:4.42%
15
152
469
4683
10
48
474
4787
—
—
6
7
475
4828
5
36
465
4776
28
201
410
4350
Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
83084-4 [42529201]
—
—
—
—
—
—
2.2e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.05%
controls:0.24%
—
—
—
—
—
—
9
11
429
4540
Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
31374-2 [3007080]
—
—
1.0e+50
—
1.0e+50
—
2.1e+00
—
—
—
—
cases:1.24%
controls:0.00%
—
—
cases:1.25%
controls:0.00%
—
—
cases:1.60%
controls:0.20%
—
—
6
0
478
4835
—
6
0
475
4835
—
7
9
431
4542
Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
88518-6 [36304997]
—
—
—
—
—
—
2.1e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.60%
controls:0.20%
—
—
—
—
—
—
7
9
431
4542
Feeling anxious/nervous/tense
P01 [2002000798]
1.2e+00
—
—
—
—
2.1e+00
8.2e-01
cases:1.65%
controls:0.50%
—
—
—
—
—
—
—
—
cases:1.49%
controls:0.19%
cases:2.74%
controls:1.23%
8
24
476
4811
—
—
—
—
7
9
463
4803
12
56
426
4495
Initiation and monitoring of IV fluid therapy
SPAT1083 [2001700184]
—
—
—
—
—
—
2.1e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.37%
controls:0.18%
—
—
—
—
—
—
6
8
432
4543
Lumbar spine and sacrum CT examination
NA3AD [2001307027]
—
—
—
—
—
—
2.1e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.37%
controls:0.18%
—
—
—
—
—
—
6
8
432
4543
Benign neoplasm: Ascending colon
D12.2 [45600580]
—
—
—
—
—
—
2.1e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.37%
controls:0.18%
—
—
—
—
—
—
6
8
432
4543
Tissue transglutaminase IgG Ab [Units/volume] in Serum
32998-7 [3046870]
—
2.1e+00
—
—
—
—
—
—
—
cases:1.45%
controls:0.19%
—
—
—
—
—
—
—
—
—
—
—
7
9
477
4826
—
—
—
—
—
pregabalin; oral
N02BF02 [955152]
6.0e-01
1.0e+00
1.3e+00
—
1.2e+00
1.0e+00
6.4e-01
cases:5.79%
controls:3.25%
cases:4.13%
controls:1.51%
cases:1.45%
controls:0.39%
—
—
cases:1.25%
controls:0.39%
cases:3.83%
controls:1.41%
cases:6.62%
controls:3.60%
28
157
456
4678
20
73
464
4762
7
19
477
4816
—
6
19
475
4816
18
68
452
4744
29
164
409
4387
Protein electrophoresis panel - Serum or Plasma
24351-9 [3004588]
—
—
—
—
—
2.0e+00
4.0e-01
—
—
—
—
—
—
—
—
—
—
cases:1.28%
controls:0.17%
cases:1.14%
controls:0.77%
—
—
—
—
—
6
8
464
4804
5
35
433
4516
levothyroxine sodium; oral, parenteral
H03AA01 [21602754]
4.9e-01
5.1e-01
3.3e-01
—
2.0e-01
5.1e-01
5.3e-01
cases:12.60%
controls:8.09%
cases:12.81%
controls:8.13%
cases:3.10%
controls:2.25%
—
—
cases:2.70%
controls:2.21%
cases:13.62%
controls:8.67%
cases:16.44%
controls:10.35%
61
391
423
4444
62
393
422
4442
15
109
469
4726
—
13
107
468
4728
64
417
406
4395
72
471
366
4080
zopiclone; oral
N05CF01 [21604654]
5.8e-01
8.2e-01
1.0e+00
—
1.0e+00
6.4e-01
4.6e-01
cases:11.36%
controls:6.70%
cases:8.68%
controls:4.03%
cases:2.89%
controls:1.08%
—
—
cases:2.70%
controls:0.99%
cases:8.09%
controls:4.43%
cases:11.87%
controls:7.82%
55
324
429
4511
42
195
442
4640
14
52
470
4783
—
13
48
468
4787
38
213
432
4599
52
356
386
4195
antibiotics in combination with corticosteroids
D01AA20 [21601918]
4.4e-01
—
—
—
—
2.0e+00
3.7e-01
cases:2.27%
controls:1.47%
—
—
—
—
—
—
—
—
cases:2.34%
controls:0.31%
cases:2.28%
controls:1.58%
11
71
473
4764
—
—
—
—
11
15
459
4797
10
72
428
4479
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M
77147-7 [46236952]
8.9e-01
2.0e+00
—
—
—
—
3.8e-01
cases:1.45%
controls:0.60%
cases:1.86%
controls:0.25%
—
—
—
—
—
—
—
—
cases:1.60%
controls:1.10%
7
29
477
4806
9
12
475
4823
—
—
—
—
7
50
431
4501
Crohn disease, unspecified
K50.9 [45562490]
2.0e+00
—
—
—
—
—
—
cases:1.24%
controls:0.17%
—
—
—
—
—
—
—
—
—
—
—
—
6
8
478
4827
—
—
—
—
—
—
Oral Surgery
19 [38004464]
9.6e-01
2.0e+00
—
—
—
—
1.0e+00
cases:1.65%
controls:0.64%
cases:1.24%
controls:0.17%
—
—
—
—
—
—
—
—
cases:2.51%
controls:0.90%
8
31
476
4804
6
8
478
4827
—
—
—
—
11
41
427
4510
clindamycin; oral, parenteral
J01FF01 [21602985]
7.4e-01
8.1e-01
—
—
-1.0e+50
1.3e+00
3.2e-01
cases:5.99%
controls:2.96%
cases:2.07%
controls:0.93%
—
—
—
—
cases:0.00%
controls:0.10%
cases:3.19%
controls:0.91%
cases:5.25%
controls:3.87%
29
143
455
4692
10
45
474
4790
—
—
0
5
481
4830
15
44
455
4768
23
176
415
4375
Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
16182-8 [3021952]
—
—
—
—
—
—
2.0e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.60%
controls:0.22%
—
—
—
—
—
—
7
10
431
4541
Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
3255-7 [3016407]
—
1.0e+50
—
—
—
—
2.0e+00
—
—
cases:1.24%
controls:0.00%
—
—
—
—
—
—
—
—
cases:2.05%
controls:0.29%
—
6
0
478
4835
—
—
—
—
9
13
429
4538
Fever, unspecified
R50.9 [45582716]
8.5e-01
2.0e+00
—
—
—
1.6e+00
9.3e-01
cases:1.86%
controls:0.81%
cases:2.07%
controls:0.29%
—
—
—
—
—
—
cases:1.28%
controls:0.25%
cases:3.42%
controls:1.38%
9
39
475
4796
10
14
474
4821
—
—
—
6
12
464
4800
15
63
423
4488
Protein [Mass/volume] in Serum or Plasma
2885-2 [3020630]
—
—
—
—
—
2.0e+00
7.4e-01
—
—
—
—
—
—
—
—
—
—
cases:1.49%
controls:0.21%
cases:2.05%
controls:0.99%
—
—
—
—
—
7
10
463
4802
9
45
429
4506
Caries of dentine
K02.1 [45548134]
-6.0e-02
1.9e-01
1.5e+00
—
7.9e-01
2.4e-01
4.5e-01
cases:8.26%
controls:8.73%
cases:4.75%
controls:3.97%
cases:1.86%
controls:0.41%
—
—
cases:1.04%
controls:0.48%
cases:5.96%
controls:4.76%
cases:20.78%
controls:14.37%
40
422
444
4413
23
192
461
4643
9
20
475
4815
—
5
23
476
4812
28
229
442
4583
91
654
347
3897
Pain in limb
M79.6 [45587063]
3.5e-01
5.2e-01
2.0e+00
—
-1.0e+50
4.5e-01
4.2e-01
cases:4.34%
controls:3.10%
cases:2.07%
controls:1.24%
cases:1.45%
controls:0.21%
—
—
cases:0.00%
controls:0.14%
cases:2.13%
controls:1.37%
cases:9.82%
controls:6.66%
21
150
463
4685
10
60
474
4775
7
10
477
4825
—
0
7
481
4828
10
66
460
4746
43
303
395
4248
Albumin [Presence] in Urine by Test strip
50949-7 [3029937]
3.6e-01
6.7e-01
2.0e+00
—
—
7.7e-01
1.2e-01
cases:3.72%
controls:2.63%
cases:3.10%
controls:1.61%
cases:1.45%
controls:0.21%
—
—
—
—
cases:3.40%
controls:1.60%
cases:7.31%
controls:6.50%
18
127
466
4708
15
78
469
4757
7
10
477
4825
—
—
16
77
454
4735
32
296
406
4255
Examination and observation for unspecified reason
Z04.9 [45605102]
—
—
—
—
—
—
2.0e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.83%
controls:0.26%
—
—
—
—
—
—
8
12
430
4539
Cystatin C [Mass/volume] in Serum or Plasma
33863-2 [3030366]
—
—
—
—
—
—
1.9e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.05%
controls:0.31%
—
—
—
—
—
—
9
14
429
4537
hydrocortisone
A07EA02 [21600654]
1.2e-01
7.0e-01
1.9e+00
—
—
6.7e-01
2.3e-01
cases:6.61%
controls:5.92%
cases:3.93%
controls:1.99%
cases:1.65%
controls:0.25%
—
—
—
—
cases:4.26%
controls:2.22%
cases:9.82%
controls:7.98%
32
286
452
4549
19
96
465
4739
8
12
476
4823
—
—
20
107
450
4705
43
363
395
4188
hydrocortisone buteprate
D07AB11 [21602115]
1.1e-01
7.1e-01
1.9e+00
—
—
7.0e-01
2.4e-01
cases:6.40%
controls:5.79%
cases:3.93%
controls:1.96%
cases:1.65%
controls:0.25%
—
—
—
—
cases:4.26%
controls:2.16%
cases:9.82%
controls:7.91%
31
280
453
4555
19
95
465
4740
8
12
476
4823
—
—
20
104
450
4708
43
360
395
4191
Acute suppurative otitis media
H66.0 [45572040]
1.9e+00
—
—
—
—
-1.0e+50
—
cases:1.65%
controls:0.25%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.17%
—
—
8
12
476
4823
—
—
—
—
0
8
470
4804
—
hydrocortisone
D07AA02 [21602102]
1.1e-01
7.1e-01
1.9e+00
—
—
7.0e-01
2.4e-01
cases:6.40%
controls:5.79%
cases:3.93%
controls:1.96%
cases:1.65%
controls:0.25%
—
—
—
—
cases:4.26%
controls:2.16%
cases:9.82%
controls:7.91%
31
280
453
4555
19
95
465
4740
8
12
476
4823
—
—
20
104
450
4708
43
360
395
4191
hydrocortisone aceponate
D07AC16 [21602135]
1.1e-01
7.1e-01
1.9e+00
—
—
7.0e-01
2.4e-01
cases:6.40%
controls:5.79%
cases:3.93%
controls:1.96%
cases:1.65%
controls:0.25%
—
—
—
—
cases:4.26%
controls:2.16%
cases:9.82%
controls:7.91%
31
280
453
4555
19
95
465
4740
8
12
476
4823
—
—
20
104
450
4708
43
360
395
4191
hydrocortisone butyrate
D07AB02 [21602106]
1.1e-01
7.1e-01
1.9e+00
—
—
7.0e-01
2.4e-01
cases:6.40%
controls:5.79%
cases:3.93%
controls:1.96%
cases:1.65%
controls:0.25%
—
—
—
—
cases:4.26%
controls:2.16%
cases:9.82%
controls:7.91%
31
280
453
4555
19
95
465
4740
8
12
476
4823
—
—
20
104
450
4708
43
360
395
4191
hydrocortisone
C05AA01 [21601608]
1.2e-01
7.0e-01
1.9e+00
—
—
6.7e-01
2.3e-01
cases:6.61%
controls:5.92%
cases:3.93%
controls:1.99%
cases:1.65%
controls:0.25%
—
—
—
—
cases:4.26%
controls:2.22%
cases:9.82%
controls:7.98%
32
286
452
4549
19
96
465
4739
8
12
476
4823
—
—
20
107
450
4705
43
363
395
4188
Low back pain
M54.5 [45553207]
6.9e-01
1.2e+00
—
—
—
-2.6e-02
3.9e-01
cases:6.40%
controls:3.31%
cases:4.13%
controls:1.26%
—
—
—
—
—
—
cases:1.28%
controls:1.31%
cases:7.99%
controls:5.56%
31
160
453
4675
20
61
464
4774
—
—
—
6
63
464
4749
35
253
403
4298
Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
7852-7 [3010130]
—
—
—
—
—
—
1.9e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.60%
controls:0.24%
—
—
—
—
—
—
7
11
431
4540
disulfiram; oral
N07BB01 [21604821]
1.9e+00
—
—
—
—
—
—
cases:1.86%
controls:0.29%
—
—
—
—
—
—
—
—
—
—
—
—
9
14
475
4821
—
—
—
—
—
—
Insertion of central venous catheter through external or internal jugular vein
TPH15 [2001309600]
2.0e+00
—
—
—
—
—
1.9e+00
cases:1.03%
controls:0.14%
—
—
—
—
—
—
—
—
—
—
cases:1.83%
controls:0.29%
5
7
479
4828
—
—
—
—
—
8
13
430
4538
propranolol; oral, parenteral
C07AA05 [21601670]
4.9e-01
4.4e-01
—
—
1.5e+00
1.1e+00
8.0e-01
cases:5.79%
controls:3.62%
cases:2.89%
controls:1.88%
—
—
—
—
cases:1.66%
controls:0.37%
cases:4.47%
controls:1.58%
cases:8.90%
controls:4.22%
28
175
456
4660
14
91
470
4744
—
—
8
18
473
4817
21
76
449
4736
39
192
399
4359
Sytologyspecimen from mouth of uterus
XLD00 [2001306651]
—
1.1e+00
—
—
—
1.9e+00
1.0e+00
—
—
cases:1.03%
controls:0.35%
—
—
—
—
—
—
cases:1.70%
controls:0.27%
cases:2.74%
controls:0.99%
—
5
17
479
4818
—
—
—
8
13
462
4799
12
45
426
4506
Other specified counselling
Z71.8 [45581061]
8.4e-01
1.1e+00
—
—
—
1.8e+00
5.9e-01
cases:3.31%
controls:1.45%
cases:2.27%
controls:0.74%
—
—
—
—
—
—
cases:4.47%
controls:0.75%
cases:6.62%
controls:3.78%
16
70
468
4765
11
36
473
4799
—
—
—
21
36
449
4776
29
172
409
4379
Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
7853-5 [3015635]
—
—
1.0e+50
—
—
—
1.8e+00
—
—
—
—
cases:1.03%
controls:0.00%
—
—
—
—
—
—
cases:1.60%
controls:0.26%
—
—
5
0
479
4835
—
—
—
7
12
431
4539
hydrocortisone and antiinfectives
S01CA03 [21603654]
4.2e-01
—
—
—
—
1.8e+00
4.7e-01
cases:1.45%
controls:0.95%
—
—
—
—
—
—
—
—
cases:1.49%
controls:0.25%
cases:1.37%
controls:0.86%
7
46
477
4789
—
—
—
—
7
12
463
4800
6
39
432
4512
Bicarbonate [Moles/volume] in Serum or Plasma
1963-8 [3016293]
—
—
—
—
—
—
1.8e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.97%
controls:0.51%
—
—
—
—
—
—
13
23
425
4528
Epstein Barr virus Ab [Presence] in Serum
49178-7 [3048929]
1.5e+00
—
1.0e+50
—
1.0e+50
—
1.8e+00
cases:1.24%
controls:0.29%
—
—
cases:1.24%
controls:0.00%
—
—
cases:1.25%
controls:0.00%
—
—
cases:2.05%
controls:0.35%
6
14
478
4821
—
6
0
478
4835
—
6
0
475
4835
—
9
16
429
4535
Bicarbonate [Moles/volume] standard in Venous blood
19232-8 [3007628]
—
—
—
—
—
—
1.8e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.74%
controls:0.48%
—
—
—
—
—
—
12
22
426
4529
Proteinase 3 Ab [Units/volume] in Serum
6968-2 [3009445]
—
—
—
—
—
—
1.8e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.74%
controls:0.48%
—
—
—
—
—
—
12
22
426
4529
Pain in joint
M25.5 [45586941]
3.6e-01
1.0e+00
-1.0e+50
—
—
6.2e-01
6.9e-01
cases:3.51%
controls:2.48%
cases:3.10%
controls:1.12%
cases:0.00%
controls:0.10%
—
—
—
—
cases:1.91%
controls:1.04%
cases:9.59%
controls:5.03%
17
120
467
4715
15
54
469
4781
0
5
484
4830
—
—
9
50
461
4762
42
229
396
4322

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
258
356
14.35
198.28
7.4
2.8
12.69
10.79
g/l
6.19
248
332
167
134
18.48
180.65
1.8
1.1
281.56
94.71
titre
1.76
32
17
240
409
10.64
151.69
5.4
2.6
0.20
0.22
g/l
1.88
220
387
97
34
35.41
148.65
1.8
1.8
—
—
—
0
0
191
291
10.18
130.42
2.1
1.7
1.38
1.36
g/l
0.07
177
268
54
22
27.50
77.50
1.2
1.1
—
—
—
0
0
195
512
5.70
74.02
6.9
2.9
20.60
8.14
umol/l
2.72
179
457
55
27
22.85
73.39
1.2
1.1
—
—
—
0
0
69
60
13.24
68.62
1.1
1.1
1.63
1.50
g/l
1.45
62
55
216
660
5.10
67.58
1.9
1.4
891.73
534.48
titre
1.49
75
163
347
1543
5.39
67.03
11.3
3.3
54.55
31.20
u/l
5.65
332
1452
388
1889
6.27
66.93
13.1
4.9
35.00
35.99
g/l
2.80
372
1784
181
514
5.02
61.15
1.6
1.6
—
—
—
0
0
69
73
10.85
60.06
1.9
1.7
0.72
0.82
g/l
0.18
58
65
65
71
10.42
55.19
1.1
1.0
—
—
—
0
0
65
72
10.27
54.61
1.1
1.1
—
—
—
0
0
411
2339
5.96
52.08
19.1
6.6
16.46
10.95
umol/l
3.66
400
2232
187
623
4.26
49.99
2.8
2.3
26.23
22.67
%
1.73
176
586
193
668
4.14
48.75
2.8
2.3
2.32
2.33
g/l
0.14
178
618
192
682
4.00
46.39
1.6
1.6
—
—
—
0
0
198
721
3.95
46.11
2.9
2.3
14.06
13.24
umol/l
0.69
185
673
354
1933
4.08
43.87
17.5
12.1
1.16
1.19
inr
0.73
314
1592
61
88
7.79
41.23
1.3
1.2
275.41
216.23
u/ml
0.56
32
44
285
1430
3.41
38.55
14.2
6.0
—
—
—
0
0
240
1089
3.38
38.30
13.2
3.9
87.29
92.21
%
2.07
233
1069
218
968
3.27
35.47
2.1
1.4
2.96
2.39
g/l
3.27
180
583
57
94
6.74
33.95
1.4
1.4
—
—
—
0
0
52
82
6.98
32.27
1.3
1.4
134.37
161.09
au/ml
0.54
14
27
344
2060
3.30
32.24
16.0
6.1
56.85
57.51
%
0.50
339
1964
342
2042
3.29
32.20
16.0
6.2
2.90
2.82
%
0.27
335
1916
342
2043
3.29
32.15
16.1
6.3
9.43
8.73
%
4.03
335
1922
269
1413
3.03
31.66
5.3
2.6
63.81
64.76
u/l
0.07
256
1313
340
2044
3.22
31.20
16.1
6.3
0.74
0.70
%
0.71
335
1909
76
178
4.88
31.00
4.7
3.3
822.40
1869.50
u/ml
0.43
71
156
67
142
5.31
30.69
1.5
1.3
—
—
—
0
0
354
2226
3.19
29.06
16.0
6.1
0.57
0.57
e9/l
0.04
332
1910
79
201
4.50
29.02
2.6
1.5
0.33
0.35
mg/l
0.09
32
81
358
2274
3.19
28.69
16.0
6.1
1.70
1.93
e9/l
3.24
338
2010
354
2236
3.16
28.63
16.0
6.1
0.04
0.04
e9/l
0.72
334
1916
157
640
3.15
28.53
2.7
1.8
30.70
29.23
s
2.53
151
620
360
2301
3.19
28.39
16.1
6.4
0.18
0.19
e9/l
0.35
337
2012
119
415
3.47
27.90
3.5
2.5
33.76
33.80
u/l
0.00
106
346
105
344
3.62
27.05
1.5
1.4
—
—
—
0
0
375
2490
3.23
26.90
18.9
9.8
3.75
4.10
e9/l
2.59
355
2172
316
2008
2.65
22.86
3.9
2.5
74.97
77.32
nmol/l
0.84
297
1801
436
3315
4.12
22.16
26.9
8.3
106.74
78.52
u/l
15.97
425
3138
48
103
5.06
21.51
1.3
1.1
—
—
—
0
0
203
1095
2.47
20.18
3.1
2.1
3.12
2.95
mg/l
0.38
185
943
58
153
4.17
20.11
1.7
1.2
—
—
—
0
0
60
167
3.96
19.32
1.7
1.9
1.31
1.48
g/l
0.64
50
151
62
177
3.87
19.27
1.7
1.5
5.49
10.90
iu/ml
—
9
6
320
2164
2.41
18.43
11.7
7.0
1.21
1.21
mmol/l
0.43
284
1875
131
598
2.63
18.27
4.1
2.3
163.58
124.90
ug/g
0.79
115
481
106
445
2.77
17.37
4.4
4.7
3.47
24.39
ug/l
1.21
85
370
25
14
18.76
16.63
3.0
2.3
4168.00
4.42
ug/l
0.49
25
14
199
1152
2.23
15.94
6.4
4.2
—
—
—
0
0
130
628
2.46
15.85
3.0
2.0
—
—
—
0
0
388
2975
2.52
15.14
10.8
3.4
127.35
45.93
u/l
11.78
371
2821
285
1946
2.13
14.51
10.0
6.2
1.21
1.22
mmol/l
0.63
270
1792
300
2097
2.13
14.25
4.0
3.0
199.44
116.89
ug/l
1.51
285
1951
214
1326
2.10
13.95
5.6
3.8
7.40
7.40
ph
1.95
165
935
339
2520
2.15
13.21
9.4
5.0
7.07
6.60
mmol/l
1.70
327
2377
20
12
17.31
13.08
1.5
1.5
—
—
—
0
0
35
89
4.16
12.68
4.8
4.2
31.14
3040.33
u/ml
0.57
30
84
81
353
2.55
12.06
2.9
2.7
72.97
74.09
e9/l
0.11
72
257
179
1088
2.02
11.86
1.5
1.3
1.82
1.26
u/ml
0.45
42
302
19
14
14.07
11.54
3.5
3.9
0.59
0.60
mmol/l
0.25
19
14
83
381
2.42
11.02
1.5
1.4
—
—
—
0
0
84
388
2.41
11.00
7.2
4.4
0.36
0.58
%
0.89
33
120
217
1441
1.92
10.88
3.9
2.2
—
—
—
0
0
267
1901
1.90
10.77
2.4
2.1
96.39
97.53
pmol/l
0.15
160
949
115
612
2.15
10.74
1.2
1.2
—
—
—
0
0
200
1326
1.86
9.82
4.0
3.0
—
—
—
0
0
137
805
1.98
9.67
1.8
1.9
—
—
—
0
0
84
411
2.26
9.58
8.0
4.3
0.61
1.03
%
1.35
35
134
21
45
4.83
9.38
1.2
1.2
8.41
6.50
g/l
0.79
11
38
21
45
4.83
9.38
1.2
1.2
—
—
—
0
0
21
45
4.83
9.38
1.2
1.2
0.53
0.37
g/l
0.59
11
37
21
45
4.83
9.38
1.2
1.2
2.98
2.80
g/l
0.11
11
37
103
553
2.10
9.29
4.2
3.0
5.23
4.76
e9/l
0.18
95
494
276
2049
1.81
9.14
3.8
2.7
—
—
estimate
—
0
0
195
1307
1.82
9.07
11.5
6.1
—
—
—
0
0
85
429
2.19
8.97
6.6
3.3
7.37
7.39
ph
1.32
45
243
98
527
2.08
8.77
2.3
1.3
—
—
—
0
0
15
14
11.01
8.34
1.8
1.6
10123.17
4685.25
e6/l
—
6
8
132
804
1.88
8.21
4.2
2.9
524.83
522.81
mosm/kgh2o
0.03
118
695
51
214
2.55
8.15
1.9
1.9
4.24
6.52
iu/ml
0.55
11
56
80
409
2.14
8.14
6.9
3.1
0.48
1.98
mmol/l
2.59
70
352
76
386
2.15
7.85
8.6
4.4
0.00
0.17
%
3.09
27
108
18
26
7.15
7.84
1.8
1.9
11.50
11.75
umol/l
0.08
18
26
357
2932
1.82
7.75
6.7
4.6
—
2.87
—
0
7
76
391
2.12
7.59
9.4
4.8
0.07
0.14
%
0.29
27
97
116
698
1.87
7.41
1.9
1.6
1157.56
1189.25
nmol/l
0.14
97
522
13
12
11.09
7.33
2.2
1.9
—
—
—
0
0
13
13
10.24
7.07
1.9
1.5
—
—
—
0
0
144
942
1.75
6.93
4.1
2.6
5.29
6.38
e6/l
0.42
132
853
254
1934
1.66
6.90
25.3
10.9
0.00
0.00
e9/l
0.72
227
1567
113
693
1.82
6.74
3.8
2.9
1.77
2.62
e6/l
0.90
63
300
31
112
2.89
6.61
2.6
3.1
1.20
1.64
index
0.26
15
61
195
1403
1.65
6.51
5.1
3.1
45.21
89.08
e6/l
0.37
157
1038
85
482
1.93
6.45
2.5
1.6
—
—
—
0
0
11
10
11.22
6.32
1.0
1.1
—
—
—
0
0
11
10
11.22
6.32
1.0
1.0
—
—
—
0
0
161
1115
1.66
6.17
4.4
2.6
357.96
333.71
umol/l
1.70
143
976
14
22
6.52
5.90
1.1
1.0
—
—
—
0
0
56
284
2.10
5.79
1.3
2.4
—
—
—
0
0
17
46
3.79
5.69
1.3
1.3
—
—
—
0
0
168
1200
1.61
5.59
4.9
3.0
0.34
0.42
e6/l
0.31
132
841
21
67
3.23
5.53
3.3
3.4
4.38
4.37
e9/l
0.01
21
67
173
1250
1.60
5.47
2.0
1.7
18.83
20.95
nmol/l
1.16
160
1058
230
1779
1.56
5.39
2.3
2.1
—
—
—
0
0
82
492
1.80
5.18
11.5
8.8
7.41
7.41
ph
0.19
43
272
211
1612
1.55
5.16
6.0
3.8
65.67
96.25
e6/l
0.54
160
1094
91
568
1.74
5.02
1.7
1.4
—
—
—
0
0
31
130
2.48
5.00
1.3
1.4
242.73
314.58
ug/g
0.96
22
73
64
360
1.90
4.95
15.8
8.3
—
—
—
0
0
173
1274
1.56
4.94
3.0
3.2
2290.75
1044.54
ng/l
0.96
164
1078
79
485
1.75
4.61
11.8
8.8
-0.24
1.00
mmol/l
1.16
59
406
125
1715
0.63
4.55
3.4
3.2
—
—
—
0
0
12
23
5.32
4.48
3.6
3.7
4008.50
812.43
u/ml
0.63
12
23
184
1403
1.50
4.36
4.6
3.4
89.67
42.14
mg/l
0.98
123
880
194
1496
1.49
4.35
4.6
3.3
6.54
7.70
mmol/l
3.60
166
1258
14
41
3.49
4.21
1.5
1.2
—
—
—
0
0
451
4197
2.06
4.15
36.6
15.2
19.61
22.36
mg/l
1.37
418
3417
124
877
1.56
4.13
1.4
1.3
39.08
35.06
iu/ml
0.12
43
275
125
886
1.55
4.13
1.8
1.7
460.82
15789910.82
pmol/l
0.50
102
741
15
47
3.26
4.09
1.0
1.2
—
—
—
0
0
118
829
1.56
4.04
3.8
4.0
247.89
340.94
ng/l
0.35
91
625
142
1041
1.51
4.00
9.0
4.7
—
—
—
0
0
65
395
1.75
3.92
8.0
4.1
7.37
7.36
ph
0.31
53
285
116
819
1.55
3.88
1.4
1.3
18.02
12.16
u/ml
0.32
37
305
31
147
2.18
3.83
4.0
3.3
205.75
249.46
mg/l
0.23
16
56
184
1434
1.46
3.79
5.3
4.1
19.15
7.26
mg/mmol
0.92
116
876
6
5
12.13
3.77
1.3
1.0
—
—
—
0
0
14
45
3.17
3.68
1.5
1.2
—
—
—
0
0
139
1034
1.48
3.61
1.9
1.7
2.16
1.20
mg/l
1.78
114
808
57
342
1.76
3.60
4.4
3.4
1.22
1.23
mmol/l
0.63
52
293
26
118
2.27
3.58
5.4
11.3
1.43
1.32
mmol/l
0.17
21
104
175
1365
1.44
3.54
2.7
2.1
143.25
235.50
u/l
1.14
170
1290
22
93
2.43
3.53
1.1
1.7
—
—
—
0
0
48
275
1.83
3.53
5.0
3.2
7.40
7.42
ph
1.08
41
231
13
36
3.68
3.52
1.2
1.1
—
—
—
0
0
12
31
3.94
3.51
2.1
1.9
44.69
43.20
%
0.11
12
31
60
369
1.71
3.48
1.2
1.2
—
—
—
0
0
25
114
2.26
3.41
1.1
1.2
—
—
—
0
0
22
97
2.33
3.24
3.4
3.0
59.82
58.67
%
0.16
22
97
26
124
2.16
3.20
1.9
2.5
12.70
11.81
mg/l
0.24
26
119
270
2309
1.38
3.08
5.3
3.9
21.05
10.32
estimate
0.20
63
476
136
1037
1.43
3.04
4.5
3.7
—
0.13
—
0
8
5
5
10.08
2.98
1.2
2.8
58.20
34.60
u/l
—
5
5
222
1848
1.37
2.95
4.7
3.5
6.22
6.21
ph
0.07
119
1047
14
52
2.74
2.91
1.3
1.2
—
—
—
0
0
189
1536
1.38
2.90
3.5
3.4
2.34
2.36
mmol/l
0.65
177
1392
9
24
3.80
2.68
1.3
1.3
—
—
—
0
0
61
404
1.58
2.68
2.5
2.1
0.30
0.04
estimate
—
10
80
451
4283
1.76
2.62
36.1
17.8
138.92
139.75
mmol/l
10.20
445
4213
269
2335
1.34
2.61
5.3
3.9
0.00
0.02
estimate
0.97
54
439
24
121
2.03
2.60
1.1
3.8
1.10
1.92
ratio
1.06
15
69
12
42
2.90
2.56
1.4
1.1
—
—
—
0
0
7
16
4.42
2.48
3.3
2.2
—
—
—
0
0
11
38
2.94
2.43
1.0
1.2
—
—
—
0
0
33
191
1.78
2.40
5.8
3.3
—
—
—
0
0
12
46
2.65
2.37
1.2
1.1
—
—
—
0
0
262
2288
1.32
2.33
5.3
3.8
0.02
0.00
estimate
0.41
60
467
450
4289
1.68
2.32
36.6
17.9
3.94
3.96
mmol/l
1.26
445
4209
11
40
2.79
2.28
2.0
1.9
90.24
90.17
%
0.02
11
40
10
35
2.90
2.22
1.5
1.5
—
—
—
0
0
5
9
5.60
2.22
3.0
1.4
—
—
—
0
0
10
36
2.81
2.15
1.5
1.4
0.45
1.12
promille
—
5
27
112
880
1.35
2.04
2.6
2.7
2.46
2.45
mmol/l
0.21
100
798
12
50
2.44
2.04
2.0
1.9
33.50
31.44
pg
1.10
12
50
39
249
1.62
2.03
1.5
1.2
—
—
—
0
0
8
26
3.11
2.02
1.7
3.3
896.63
1042.50
mg
—
8
26
31
187
1.70
1.99
1.2
1.2
—
—
—
0
0
18
91
2.02
1.97
1.2
1.2
—
—
—
0
0
14
64
2.22
1.96
1.5
1.3
—
—
—
0
0
13
58
2.28
1.92
1.4
1.4
—
—
—
0
0
13
58
2.28
1.92
1.4
1.4
—
—
—
0
0
13
58
2.28
1.92
1.4
1.4
—
—
—
0
0
13
58
2.28
1.92
1.4
1.4
—
—
—
0
0
76
569
1.40
1.86
1.2
1.3
—
—
—
0
0
6
17
3.56
1.84
1.8
1.5
—
—
—
0
0
5
12
4.20
1.82
1.2
1.4
—
—
—
0
0
5
12
4.20
1.82
1.0
1.8
34.80
26.08
%
—
5
12
194
1671
1.27
1.78
4.9
3.7
43.32
72.64
ng/l
0.37
145
1153
23
132
1.78
1.77
1.8
2.6
—
—
—
0
0
23
132
1.78
1.77
3.1
3.6
1.36
1.35
mmol/l
0.02
23
126
6
146
0.40
1.67
1.2
1.1
1.55
1.56
g/l
—
6
146
11
49
2.27
1.64
1.1
1.1
—
—
—
0
0
10
42
2.41
1.62
1.2
1.1
—
—
—
0
0
10
42
2.41
1.62
1.2
1.1
—
—
—
0
0
35
232
1.55
1.59
4.7
6.8
—
—
—
0
0
10
44
2.30
1.56
3.9
1.9
11.82
10.81
%
—
10
44
20
115
1.77
1.55
1.2
1.2
706.40
467.09
mg/l
0.34
20
107
5
15
3.36
1.52
4.8
1.5
—
—
—
0
0
7
27
2.62
1.52
1.0
3.8
16.16
16.64
%
—
7
27
18
102
1.79
1.47
1.1
1.2
4.79
3.77
mmol/l
0.69
18
93
7
28
2.52
1.45
1.6
1.3
—
—
—
0
0
6
22
2.75
1.44
3.3
3.0
—
—
—
0
0
48
349
1.42
1.42
3.5
2.4
6.14
6.11
ph
0.09
38
231
17
96
1.80
1.40
2.5
2.6
127.20
76.71
ug/min
—
9
53
22
346
0.62
1.40
1.9
1.9
3.18
3.54
mmol/l
0.44
13
262
5
18
2.80
1.29
1.6
3.4
—
—
—
0
0
14
77
1.84
1.26
5.1
2.6
7.64
8.09
pmol/l
0.06
14
77
15
85
1.79
1.24
1.1
2.0
3.97
5.17
mmol/24h
0.70
15
75
145
1261
1.21
1.15
4.5
3.3
4.98
0.01
estimate
0.50
51
373
14
81
1.75
1.10
1.9
1.5
—
—
—
0
0
5
21
2.39
1.09
1.4
1.4
—
—
—
0
0
7
32
2.20
1.08
1.4
2.0
—
—
—
0
0
13
74
1.78
1.07
1.9
1.4
—
—
—
0
0
7
33
2.14
1.06
2.3
1.4
8.81
6.71
u/l
—
7
28
5
22
2.29
1.03
4.4
3.6
1.40
0.91
index
—
5
22
21
139
1.53
1.02
2.4
2.0
0.78
2820.02
u/l
—
5
51
7
35
2.01
1.00
1.6
1.7
4.96
4.00
mg/l
—
7
35
30
215
1.42
1.00
3.0
2.2
0.30
0.01
estimate
—
10
68
169
1510
1.18
0.98
4.5
3.5
—
0.60
—
0
5
6
28
2.16
0.92
1.0
1.1
—
—
—
0
0
454
4436
1.37
0.91
32.7
12.1
39.26
25.71
u/l
14.61
448
4324
27
196
1.40
0.86
2.8
1.8
—
—
—
0
0
32
240
1.36
0.85
6.0
2.4
1.44
1.23
%
0.78
32
240
21
146
1.46
0.84
1.5
1.4
308.73
241.92
miu/ml
0.32
11
68
28
206
1.38
0.83
2.7
2.3
—
—
—
0
0
15
98
1.55
0.79
1.1
1.1
56.60
10.65
e6/l
—
10
72
0
25
0.00
0.79
0.0
7.3
—
600.75
—
0
19
0
25
0.00
0.79
0.0
1.0
—
0.13
—
0
11
17
115
1.50
0.78
2.0
1.5
8260.27
18243.25
e6/l
0.76
11
83
113
998
1.17
0.75
5.4
3.9
1.02
1.02
kg/l
0.24
81
653
9
54
1.68
0.75
2.2
3.0
—
—
—
0
0
139
1249
1.16
0.74
1.5
1.4
—
—
—
0
0
31
238
1.32
0.73
6.1
2.4
0.63
0.60
%
0.18
31
238
9
56
1.62
0.72
1.1
1.1
—
—
—
0
0
353
3391
1.15
0.69
4.7
4.5
14.77
14.79
pmol/l
0.04
332
3108
9
59
1.54
0.68
2.8
2.9
—
—
—
0
0
7
42
1.68
0.68
1.9
2.8
—
—
—
0
0
188
1737
1.13
0.67
5.3
3.7
2.26
0.03
estimate
0.52
47
395
21
154
1.38
0.66
3.0
1.2
0.88
0.92
g/l
0.39
21
154
11
71
1.56
0.62
1.2
1.2
—
—
—
0
0
25
191
1.33
0.62
1.1
1.1
—
—
—
0
0
0
20
0.00
0.60
0.0
1.0
—
0.21
—
0
5
0
21
0.00
0.60
0.0
1.0
—
0.24
—
0
6
15
106
1.43
0.58
10.6
5.0
—
—
—
0
0
11
73
1.52
0.56
1.1
1.1
—
14.76
—
0
22
39
322
1.23
0.55
3.4
2.6
23.04
18.92
au/ml
—
7
26
6
38
1.59
0.54
1.2
2.7
—
—
—
0
0
407
3974
1.15
0.51
6.0
5.5
1.95
1.90
mu/l
0.40
389
3683
410
4006
1.15
0.51
5.1
4.3
1.32
1.28
mmol/l
0.52
393
3705
366
3551
1.13
0.51
43.3
18.8
14.24
13.60
%
9.17
366
3515
7
45
1.56
0.49
1.7
2.6
—
—
—
0
0
54
620
0.85
0.48
2.9
3.1
0.77
0.75
ug/l
0.03
45
381
36
301
1.21
0.47
2.2
2.4
14.12
13.72
nmol/l
0.08
30
278
16
120
1.34
0.46
1.3
1.9
54.25
39.61
nmol/l
0.80
16
114
19
147
1.30
0.46
1.2
1.1
—
—
—
0
0
9
127
0.70
0.44
7.6
10.0
—
—
—
0
0
38
323
1.19
0.43
1.2
1.3
—
—
—
0
0
13
96
1.36
0.42
5.9
1.9
65.00
60.42
%
0.39
13
96
41
475
0.85
0.42
1.7
1.5
—
—
—
0
0
0
15
0.00
0.41
0.0
1.3
—
58.00
—
0
15
33
278
1.20
0.41
7.5
3.0
111.55
130.09
g/l
3.89
33
272
24
196
1.24
0.40
12.5
3.2
23.25
25.05
mmol/l
1.68
24
191
135
1268
1.09
0.34
5.0
3.8
0.02
0.01
estimate
0.13
57
440
6
89
0.67
0.33
6.8
3.9
16.83
25.74
u/ml
—
6
89
15
119
1.27
0.32
5.8
2.6
62.15
60.69
%
0.12
15
114
20
239
0.83
0.30
1.0
1.1
—
—
—
0
0
11
84
1.32
0.30
6.4
3.0
—
—
—
0
0
7
55
1.28
0.30
1.1
1.3
—
—
—
0
0
425
4193
1.11
0.29
6.4
5.2
4.51
4.69
mmol/l
2.82
408
3928
15
121
1.25
0.29
1.5
1.9
3.51
4.76
iu/l
—
6
46
10
76
1.32
0.28
1.1
1.2
—
—
—
0
0
99
1055
0.92
0.27
5.5
5.0
2.12
2.40
ug/l
0.25
92
948
8
64
1.25
0.27
1.1
1.3
0.60
0.59
nmol/l
—
8
59
195
1876
1.07
0.27
2.4
1.9
1.30
1.34
mmol/l
0.33
171
1579
5
74
0.67
0.26
1.0
1.2
3.60
4.32
u/ml
—
5
28
36
321
1.13
0.25
1.2
1.2
70.84
127.94
u/ml
—
10
133
20
172
1.17
0.22
2.3
1.5
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
0.02
—
0
10
18
209
0.86
0.21
2.3
1.7
—
—
—
0
0
6
48
1.25
0.20
1.3
1.4
22.28
30.58
ng/l
—
6
48
20
174
1.16
0.20
2.3
1.5
—
—
—
0
0
20
174
1.16
0.20
2.6
1.5
—
—
—
0
0
20
175
1.15
0.19
2.4
1.5
—
—
—
0
0
413
4090
1.07
0.17
6.4
5.1
6.09
5.90
mmol/l
1.89
394
3787
38
350
1.09
0.17
4.8
3.7
—
—
—
0
0
429
4323
0.93
0.15
28.5
13.6
—
—
—
0
0
9
81
1.11
0.15
1.4
1.9
—
—
—
0
0
9
81
1.11
0.15
3.7
1.8
—
—
—
0
0
421
4177
1.06
0.14
6.2
5.1
1.44
1.49
mmol/l
1.73
402
3895
395
3979
0.96
0.10
8.5
6.3
40.11
39.11
mmol/mol
1.27
381
3758
43
409
1.06
0.09
1.6
1.8
—
—
—
0
0
5
61
0.82
0.08
1.0
1.2
—
—
—
0
0
7
67
1.05
0.08
5.1
5.3
361.29
350.34
umol/l
—
7
59
6
71
0.84
0.07
1.2
1.2
—
—
—
0
0
8
75
1.07
0.07
1.1
1.1
—
—
—
0
0
8
75
1.07
0.07
1.1
1.1
—
—
—
0
0
43
448
0.96
0.07
1.9
1.5
—
—
—
0
0
11
99
1.11
0.06
1.3
1.9
199.45
223.48
pmol/l
0.20
11
93
427
4253
1.03
0.06
6.8
5.9
2.60
2.74
mmol/l
2.64
407
3973
17
161
1.06
0.03
2.5
1.5
—
—
—
0
0
13
138
0.94
0.02
1.5
1.3
—
—
—
0
0
456
4554
1.02
0.00
53.3
23.7
39.39
40.44
%
4.36
451
4511
11
107
1.03
0.00
1.5
1.8
—
—
—
0
0
5
51
0.98
-0.00
1.6
2.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
0.03
—
0
5
12
120
1.00
-0.00
1.1
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
8
0.00
-0.00
0.0
2.4
—
2.75
—
0
8
0
9
0.00
-0.00
0.0
1.3
—
9.22
—
0
9
5
55
0.91
-0.00
15.0
2.9
106.00
105.76
mmol/l
—
5
55
0
5
0.00
-0.00
0.0
1.2
—
0.06
—
0
5
0
5
0.00
-0.00
0.0
2.2
—
0.52
—
0
5
0
6
0.00
-0.00
0.0
1.0
—
0.43
—
0
6
0
5
0.00
-0.00
0.0
1.4
—
58.90
—
0
5
0
5
0.00
-0.00
0.0
1.0
—
81.50
—
0
5
6
60
1.00
-0.00
1.3
1.5
24.28
26.59
u/l
—
6
51
5
55
0.91
-0.00
15.0
2.9
1.20
1.19
mmol/l
—
5
55
5
55
0.91
-0.00
15.0
2.9
4.06
4.03
mmol/l
—
5
55
0
8
0.00
-0.00
0.0
1.5
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
50.29
—
0
7
0
6
0.00
-0.00
0.0
1.5
—
41.67
—
0
6
0
8
0.00
-0.00
0.0
2.4
—
2336.25
—
0
8
0
6
0.00
-0.00
0.0
1.5
—
58.83
—
0
6
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint CHRONHEP_NAS and mortality.

Females

Parameter HR [95% CI] p-value
CHRONHEP_NAS 2.925 [2.5, 3.42] < 0.001
Birth year 0.991 [0.98, 1.0] 0.054

During the follow-up period (1.1.1998 — 31.12.2019), 507 out of 1704 females with CHRONHEP_NAS died.

Males

Parameter HR [95% CI] p-value
CHRONHEP_NAS 3.58 [2.98, 4.31] < 0.001
Birth year 0.987 [0.98, 1.0] 0.008

During the follow-up period (1.1.1998 — 31.12.2019), 430 out of 1151 males with CHRONHEP_NAS died.

Mortality risk

Mortality risk for people of age

years, who have CHRONHEP_NAS.

N-year risk Females Males
1 0.192% 0.504%
5 1.625% 3.958%
10 3.561% 9.484%
15 6.913% 18.168%
20 12.624% 29.866%

Relationships between endpoints

↥

Index endpoint: CHRONHEP_NAS – Chronic hepatitis NAS

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data